Nvidia čeká na výsledky za 2. čtvrtletí; trh sleduje hlavně vývoj platformy Vera Rubin a hrubou marži. Odhad tržeb je 91,85 miliardy USD a upravený zisk 2,09 USD na akcii.
Nvidia (NVDA - Free Report) will step back into the earnings spotlight after the market closes on Wednesday, August 26, when the AI chip leader reports its much-anticipated Q2 results.
Expectations are understandably elevated, but the setup looks increasingly interesting as Nvidia’s valuation has compressed despite extraordinary earnings growth.
Beyond another potential top-and-bottom-line beat, Wall Street will be focused on the Vera Rubin product ramp, gross margins, and Nvidia’s growing role in financing the massive buildout of AI infrastructure.
Investors are certainly wondering if NVDA can gain momentum with shares up a somewhat subpar 12% year to date despite sitting on enormous gains of +800% in the last five years.
Image Source: Zacks Investment Research
Nvidia's Q2 ExpectationsThe Zacks Consensus Estimate calls for Nvidia to post Q2 revenue of $91.85 billion, representing a whopping 96% increase from $46.74 billion in the year-ago period. Adjusted earnings are projected at $2.09 per share, up 99% year over year.
Those projections are essentially in line with Nvidia's own guidance for $91 billion in revenue, plus or minus 2%, which notably assumes no Data Center compute revenue from China. Data Center sales remain the primary growth engine, with the Zacks Consensus calling for roughly $85.14 billion, or 107% YoY growth.
Is the Vera Rubin Ramp Taking Off?Perhaps more important than the headline Q2 numbers will be Nvidia's commentary surrounding its next-generation Vera Rubin platform, the company’s latest rack-scale AI supercomputer architecture designed to power the next era of agentic AI — systems that can reason, plan, and execute multi-step workflows at massive scale.
Nvidia announced in May that Vera Rubin was ramping into full production, with production shipments slated to begin this fall. More recently, the company said Rubin-based racks are already running at partners including CoreWeave (CRWV - Free Report) ), Alphabet’s (GOOGL - Free Report) ) Google Cloud, Microsoft’s (MSFT - Free Report) ) Azure, Oracle (ORCL - Free Report) ) Cloud Infrastructure, and Nebius (NBIS - Free Report) ).
Therefore, investors shouldn't necessarily expect Rubin to be a major Q2 revenue contributor. Instead, Wall Street will be looking for evidence that production remains on schedule, customer deployments are accelerating, and Rubin can provide another powerful growth leg as Nvidia's Blackwell series of AI chips matures. Any indication that Rubin is pulling forward orders could strengthen expectations for the second half of Nvidia's current fiscal 2027 and FY28.
Gross Margins Remain a Key CheckpointNvidia's profitability will also be closely scrutinized. Management guided for a 75% non-GAAP gross margin, plus or minus 50 basis points, essentially matching the 75% achieved during Q1.
That stability is important as investors assess higher memory and component costs associated with increasingly sophisticated AI systems. Some analysts expect modest pressure during the Rubin transition, but maintaining gross margins in the mid-70% range would reinforce Nvidia's enormous pricing power and help alleviate concerns that escalating hardware costs are eating into profitability.
Image Source: Zacks Investment Research
How Much of Nvidia's Balance Sheet Is Supporting the AI Boom?Another emerging concern is Nvidia's increasingly aggressive effort to help finance the infrastructure that ultimately purchases its chips.
Most notably, Nvidia has provided up to roughly $105 billion of financial backing tied to an OpenAI data-center project in Ohio and is investing another $1.5 billion in SB Energy to support those efforts. Importantly, the $105 billion figure is a contingent backstop involving certain lease, power, and residual-value obligations rather than an immediate $105 billion cash expenditure.
Nvidia has also teamed with major Wall Street firms on a framework intended to mobilize more than $500 billion of third-party capital for AI infrastructure, which could shift more of the financing burden away from Nvidia itself.
Still, investors have reason to monitor the exposure, even with Nvidia ending Q1 with nearly $80.6 billion in cash and equivalents, while generating an exceptional $50.3 billion of operating cash flow during the quarter.
The balance sheet remains extremely strong, but Wall Street will want greater clarity on how much capital Nvidia ultimately intends to put behind customers and AI infrastructure projects, especially if these commitments keep expanding.
Image Source: Zacks Investment Research
Nvidia's Valuation May Be More Attractive Than It LooksDespite Nvidia's massive market capitalization, its valuation no longer looks particularly excessive relative to its growth rate.
NVDA is trading at 24X forward earnings, near the low end of its five-year P/E valuation range. Furthermore, Nvidia’s PEG ratio is around 0.34 with the optimum level being less than 1.0, meaning investors are paying less than one unit of P/E multiple for each unit of expected earnings growth—a metric that can make Nvidia look surprisingly inexpensive on a growth-adjusted basis.
This valuation disconnect has caught Wall Street's attention. Bank of America (BAC - Free Report) ) has argued that Nvidia is significantly undervalued compared with other AI-compute names, while Cantor Fitzgerald has similarly suggested the market is failing to fully price in Nvidia's longer-term earnings power.
Of course, PEG ratios become less useful when growth rates are exceptionally high, but Nvidia's combination of nearly triple-digit Q2 earnings growth and a mid-20s forward P/E certainly makes its valuation harder to characterize as expensive.
Image Source: Zacks Investment Research
Bottom Line: Is NVDA Stock a Buy Before Earnings?Nvidia still has plenty to prove when it reports Wednesday. Investors will want another strong quarter, an encouraging Vera Rubin ramp, resilient gross margins, and reassurance that the company's expanding AI-financing ambitions won't create unnecessary balance-sheet risk.
That said, a 24X forward P/E looks increasingly compelling if Nvidia can sustain even a fraction of its current earnings growth rate. The long-term AI investment thesis remains strong, although elevated expectations could produce significant post-earnings volatility even if results exceed consensus estimates.
For now, NVDA lands a Zacks Rank #3 (Hold), suggesting investors may want to maintain existing positions while looking for Wednesday's report to provide the next catalyst for a more bullish stance.
Digital Realty byla v Singapuru vybrána k výstavbě nového datového centra s kapacitou 50 MW na Jurong Island. Projekt má podpořit AI-ready a udržitelnou digitální infrastrukturu.
Digital Realty’s new Jurong Island location will expand its Singapore platform with AI-ready, sustainable capacity designed to support the country’s next chapter of digital growth | Source: Digital Realty Trust, L.P.
AUSTIN, Texas, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world's largest cloud- and carrier-neutral data center platform, today announced it has been selected under Singapore’s second Data Center Call for Application (DC-CFA2), with a provisional allocation of 50 megawatts (MW) of capacity to develop a new data center at Jurong Town Corporation’s low-carbon data center park on Jurong Island – a milestone that reinforces Singapore’s position as a trusted, connected and sustainable digital infrastructure hub for Asia.
The selection marks the next phase of Digital Realty’s long-term growth in Singapore and will expand the company’s ability to support customers deploying the next wave of AI inference, high-performance computing and enterprise digital workloads across Asia Pacific. Purpose-built for Singapore’s digital economy priorities, the new facility will be designed to meet DC-CFA2’s requirements for best-in-class energy efficiency and power more than 50% of its capacity through green energy pathways.
Digital Realty was selected through an open competitive process led by the Singapore Economic Development Board (EDB) and the Infocomm Media Development Authority (IMDA). The awarded proposals were recognized for their ability to strengthen Singapore’s position as a trusted hub for AI, digital infrastructure and network connectivity, as well as to contribute to innovation and economic development, and advance the country’s sustainability objectives.
“Singapore has long been a strategic market for Digital Realty, and we are honored to be selected under DC-CFA2 at such an important moment for the country’s digital future,” said Serene Nah, Managing Director and Head of Asia Pacific, Digital Realty.
“Through DC-CFA2, we plan to expand on Jurong Island with next-generation AI-ready infrastructure. Sustainability is central to how we operate at Digital Realty, and we are committed to scaling responsibly as demand grows. We are grateful to the Singapore Government, lead agencies, our customers and partners for their continued trust and collaboration, and to our employees whose dedication makes this possible. We look forward to providing additional infrastructure to sustainably serve our customers in this leading global digital hub,” she continued.
Singapore has been a cornerstone of Digital Realty’s Asia Pacific strategy since establishing operations in the country in 2010. Today, it is home to Digital Realty’s regional Asia Pacific headquarters, Global Command Center, and three operational data centers with approximately 84 MW of combined capacity - giving the company a deep operating base from which to support Singapore’s continued growth as a regional digital hub.
Demand for digital infrastructure continues to grow as organizations expand cloud adoption, digital services, and enterprise data processing. AI is accelerating this growth across industries, including financial services, technology, logistics, and healthcare - sectors where Singapore plays an important regional role. As enterprises increasingly deploy AI in production, infrastructure requirements are also evolving. AI inference requires workloads to be located closer to users and enterprise data, supported by strong connectivity, resilience, and security.
Singapore’s combination of connectivity, trusted governance, and highly developed digital ecosystem positions it to play an increasingly important role in supporting these workloads across the region. Once operational, Digital Realty’s fourth Singapore data center is expected to strengthen this role by expanding the capacity available for high-value AI and enterprise deployments, connecting customers to its global PlatformDIGITAL® ecosystem. The new facility will expand Digital Realty’s interconnected Singapore campus and is connected globally via ServiceFabric®, a service orchestration platform that connects the campus with other Digital Realty and 3rd party data centers globally to enable seamless connectivity, data exchange, and workload deployment across sites.
The new Jurong Island facility will also build on Digital Realty’s longstanding sustainability initiatives in Singapore. The company’s existing Singapore operations already achieve 100% renewable energy coverage through direct retail energy agreements with Tuas Power. Digital Realty has also collaborated with IMDA on Singapore’s tropical data center standard, demonstrating that higher chilled-water operating temperatures can improve energy efficiency without compromising operational resilience.
Drawing on the tropical data center standard, Digital Realty increased operating temperatures by 2°C across two data halls, reducing overall energy consumption by approximately 2-3% during the pilot period. In addition, Digital Realty uses sophisticated Building Management Systems to monitor more than 30,000 infrastructure points across its Singapore facilities, including real-time Power Usage Effectiveness (PUE).
Digital Realty plans to continue investing in resilient digital infrastructure, advancing energy and resource efficiency, and deepening local partnerships that support innovation, talent development and Singapore’s long-term digital competitiveness.
About Digital Realty
Digital Realty brings companies and data together by delivering the full spectrum of data center, colocation, and interconnection solutions. PlatformDIGITAL®, the company’s global data center platform, provides customers with a secure data meeting place and a proven Pervasive Datacenter Architecture (PDx®) solution methodology for powering innovation, from cloud and digital transformation to emerging technologies like artificial intelligence (AI), and efficiently managing Data Gravity challenges. Digital Realty gives its customers access to the connected data communities that matter to them with a global data center footprint of 300+ facilities in 55+ metros across 30+ countries on six continents. To learn more about Digital Realty, please visit digitalrealty.com or follow us on LinkedIn and X.
Investor Relations
Jordan Sadler / Jim Huseby
Digital Realty
(737) 281 – 0101 [email protected]
Safe Harbor Statement
This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the company's partnerships and expected benefits, expected completion dates, emerging technologies, artificial intelligence, sustainability goals, certifications and strategy and potential impact from sustainability initiatives customer demand and the company's strategy. For a list and description of risks and uncertainties, see the reports and other filings by the company with the U.S. Securities and Exchange Commission. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Plug Power ve čtvrtletí snížil ztrátu na 188 milionů USD z 1,7 miliardy USD ve stejném období před rokem. Hrubá marže se zlepšila na minus 1,7 milionu USD z hrubé ztráty 53,5 milionu USD.
Under new CEO Jose Luis Crespo, Plug Power (PLUG -4.41%) seems to be staging an impressive turnaround.
In 2025, under its former CEO, the popular hydrogen stock posted a massive $1.7 billion loss. Compare that figure to Plug Power's $3.2 billion market cap, and you can quickly appreciate the company's dire financial position.
Last quarter, however, Plug Power posted a loss of just $188 million, a run rate below $800 million per year. While not an obvious cause for celebration, narrowing losses suggest the company is headed in the right direction. Gross profit came in at negative $1.7 million, a sizable improvement to the $53.5 million gross loss posted the year prior.
Image source: Getty Images.
While unprofitable, Plug Power's management team claims roughly $2 billion in liquidity, though only $162 million is liquid cash, with another $672 million in restricted cash.
Rising sales of its GenEco hydrogen fuel systems, as well as rising hydrogen fuel sales thanks to a larger installed base, have Wall Street fairly bullish on the embattled stock. An average 12-month price target of $3.20 per share suggests roughly 40% in potential upside. Notably, two analysts recently reaffirmed their predictions, forecasting upside of 117% and 205%, respectively.
After a brief correction, Plug Power stock is roughly flat on the year despite the seeming turnaround. Should retail investors take advantage of the pullback? You may be surprised by the answer.
Today's Change
(
-4.41
%) $
-0.10
Current Price
$
2.17
Here's what Wall Street gets wrong about Plug Power's turnaround Plug Power's turnaround seems to have real legs. Revenue is rising by double digits due to strong demand for the company's GenEco hydrogen fuel systems. Earlier this year, Plug Power secured the largest order in its history: a 275-PEM electrolyzer system for Hy2gen, a Canadian conglomerate.
Rising demand has Wall Street excited not only about revenue growth potential but also about the prospect of reaching profitability. That would be huge, since Plug Power has yet to realize sustainable profits since its founding nearly three decades ago.
The issue with Plug Power as an investment doesn't strictly have to do with the company itself but with the industry it competes in. Many expert long-term forecasts of hydrogen demand have been cut in recent years for one simple reason: Hydrogen remains uneconomic relative to competing fuels such as natural gas, wind, and solar.
"We forecast the amount of hydrogen produced in 2050 will be 35% lower than we forecast in 2022. Clean hydrogen will see an even bigger decrease of 45%," one industry report concluded earlier this month. "Like most mainstream forecasters of the energy transition, the high cost of hydrogen and the lack of policy implementation have led us to revise our outlook."
Given this dynamic, Plug Power's end market demand will largely remain reliant on government subsidies and regulatory actions. In short, the company simply doesn't control its own future. So, while turnaround efforts are gaining traction, I remain leery that Plug Power will reach sustainable profits by the end of the decade.
HOUSTON--(BUSINESS WIRE)--WM (NYSE: WM) today announced the declaration of a quarterly cash dividend of $0.945 per share payable September 25, 2026, to stockholders of record on September 11, 2026.
ABOUT WM
WM (WM.com) is North America's leading provider of comprehensive environmental solutions. Previously known as Waste Management and based in Houston, Texas, WM is driven by commitments to put people first and achieve success with integrity. WM, through its subsidiaries, provides collection, recycling and disposal services to millions of residential, commercial, industrial, medical and municipal customers throughout the U.S. and Canada. With innovative infrastructure and capabilities in recycling, organics and renewable energy, WM provides environmental solutions to and collaborates with its customers in helping them pursue their sustainability goals. In North America, WM has the largest disposal network and collection fleet, is the largest recycler and is a leader in beneficial use of landfill gas, with a growing network of renewable natural gas plants and the most landfill gas-to-electricity plants, as well as the largest heavy-duty natural gas truck fleet in the industry. WM, through its subsidiaries, also provides collection and disposal services of regulated medical waste and secure information destruction services in the U.S., Canada and Western Europe. To learn more about WM and the company's sustainability progress and solutions, visit Sustainability.WM.com.
Lennar v poslední seanci vzrostl o 1,31 % na 88,16 USD a za měsíc přidal 2,81 %. Trh očekává výsledky s EPS 1,31 USD a tržbami 8,33 mld. USD, obojí meziročně níž.
Lennar (LEN - Free Report) ended the recent trading session at $88.16, demonstrating a +1.31% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a loss of 0.28% for the day. On the other hand, the Dow registered a gain of 0.26%, and the technology-centric Nasdaq decreased by 0.77%.
Coming into today, shares of the homebuilder had gained 2.81% in the past month. In that same time, the Construction sector lost 1.81%, while the S&P 500 gained 2.31%.
Market participants will be closely following the financial results of Lennar in its upcoming release. In that report, analysts expect Lennar to post earnings of $1.31 per share. This would mark a year-over-year decline of 34.5%. Alongside, our most recent consensus estimate is anticipating revenue of $8.33 billion, indicating a 5.42% downward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $5.46 per share and a revenue of $32.27 billion, signifying shifts of -32.26% and -5.6%, respectively, from the last year.
Investors might also notice recent changes to analyst estimates for Lennar. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Lennar is holding a Zacks Rank of #5 (Strong Sell) right now.
Looking at its valuation, Lennar is holding a Forward P/E ratio of 15.94. Its industry sports an average Forward P/E of 14.47, so one might conclude that Lennar is trading at a premium comparatively.
Meanwhile, LEN's PEG ratio is currently 2.92. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Building Products - Home Builders industry held an average PEG ratio of 2.92.
The Building Products - Home Builders industry is part of the Construction sector. This group has a Zacks Industry Rank of 104, putting it in the top 43% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Trump Media hájí Truth API jako běžnou technologii sociálních sítí a chce jej licencovat i platformám pro drobné investory. Firma už má více než deset smluv o odběru a přidala jednoho z největších distributorů finančních dat.
Interim CEO Kevin McGurn at Trump Media & Technology Group (NASDAQ:DJT) used a television appearance on CNBC to defend the company’s newest revenue product, the Truth API, describing the underlying technology as standard practice across large social platforms. Speaking on CNBC on August 24, 2026, roughly four months into the role, McGurn framed the paid data feed as a response to institutional demand and a scalable licensing opportunity for the company.
The product, which launched on August 1, 2026, offers institutional customers low-latency access to public Truth Social posts. Trump Media disclosed more than ten customer agreements at the time of its Q2 report, and McGurn told CNBC the company had signed one of the largest financial data and information distributors at the end of last week.
McGurn’s Three-Part Defense of the Truth API McGurn’s argument rested on three points:
First, he characterized the demand as organic: “This was demand that came to us from the market. So we wanted to make sure that we satisfy that demand in the most brightly lit way for us.”
Second, he described the underlying technology as commonplace across social media: “The technology is a tried and true technology that’s been in the social media system for quite some time, more than a decade. So all of your big platforms run APIs into high frequency trading platforms, news and information services, prediction markets, you name it.”
Third, he framed the 50 millisecond speed advantage as a byproduct of internet delivery paths: “His information goes out all over the internet. It starts on Truth Social. It goes to Twitter, it goes to Reddit, and it goes to Instagram and TikTok. We give a 50 millisecond advantage in that post, but that is the internet delivery, right?”
He drew an analogy to legacy news access: “It’s the same reason why you have reporters on Air Force One. It’s the same reason why you have a White House press room, to get closer to the information.” McGurn did not directly address the central concern raised by critics, that family ownership of the company creates a conflict-of-interest question when institutional traders get earlier access to potentially market-moving presidential statements.
Congress and the Courts Are Starting to Push Back Senate Democrats have proposed legislation targeting the Truth API, and lawsuits have been filed alleging the president is unconstitutionally monetizing his position. These remain allegations and pending matters.
Economist Peter Schiff has publicly argued that presidential ownership makes the arrangement “not standard,” a view McGurn’s industry-comparison framing implicitly contests.
Trump Media Wants to Take the API From Wall Street to Main Street CEO McGurn outlined plans to expand distribution: “We want to license this not just to high-frequency trading platforms, but to retail trading platforms. So you take it from Wall Street to Main Street, and then go on to other types of information services.” He mentioned large language models and prediction markets as additional targets.
Trump Media reported Q2 revenue of $1.70 million, up 92.46% year over year, and a net loss of $238.11 million driven largely by $190.40 million in non-cash unrealized losses on digital assets and equity securities, per the Q2 earnings release. Shares closed at $9.30 on August 22, down 29.76% year to date and 47.64% over the trailing year.
Key Takeaways The open question for investors is whether Truth API revenue can scale into retail brokers, LLMs, prediction markets, and major data distributors while regulatory and legal scrutiny remains unresolved. McGurn, who has worked in the media business for almost 30 years, is betting the answer is yes. Watch quarterly disclosures on customer count and Truth API bookings, alongside the proposed Q4 2026 close of the TAE Technologies merger, for the next update.
Contact [email protected] for any questions or corrections.
Centrus Energy v Piketonu rozjela miliardovou expanzi závodu na obohacování uranu. Projekt má v Ohiu podpořit 1 000 stavebních a 300 provozních míst a zachovat 150 stávajících.
Ohio's growing role in strengthening U.S. energy security, advanced manufacturing, and the domestic nuclear fuel supply chain highlighted by state, federal, and industry leaders
High resolution photos/video of the Governor's tour are available HERE.
Additional photos and b-roll of the Piketon facility are HERE.
, /PRNewswire/ -- Centrus Energy (NYSE: LEU) today welcomed Ohio Governor Mike DeWine, Lt. Governor Jim Tressel, JobsOhio CEO J.P. Nauseef and other state, federal and community leaders to its uranium enrichment facility in Piketon, Ohio, for a discussion on Ohio's role in rebuilding America's domestic nuclear fuel supply chain and strengthening U.S. energy and economic security.
In September 2025, Centrus joined with Governor DeWine, Senator Jon Husted, Congressman Dave Taylor and other state and federal leaders to announce the company's multi-billion-dollar expansion of its uranium enrichment plant in Piketon, which is now underway.
"Ohio has created the conditions for companies like Centrus to make substantial investments and plan for the long term," said Amir Vexler, President and CEO of Centrus. "As we expand our operations here in Piketon, we are restoring a critical domestic capability, strengthening America's nuclear fuel supply chain, and creating opportunities for the next generation of Ohioans to build careers in one of our nation's most strategic industries. We are grateful for Governor DeWine's leadership and for the partnership of JobsOhio, the U.S. Department of Energy, and the local community as we work together to build America's energy future."
Centrus' expansion is expected to support 1,000 construction jobs in Ohio and 300 new operating jobs while retaining 150 existing jobs at the facility. The investment builds on Ohio's leadership in advanced manufacturing and workforce development and reflects the collaboration among government, industry and local communities that is helping position the state at the center of efforts to rebuild America's industrial base and secure its energy future.
About Centrus
Centrus Energy is a trusted American supplier of nuclear fuel and services for the nuclear power industry, helping meet the growing need for clean, affordable, carbon-free energy. Since 1998, the Company has provided its utility customers with more than 1,850 reactor years of fuel, which is equivalent to more than 7 billion tons of coal. With world-class technical and engineering capabilities, Centrus is pioneering production of High-Assay, Low-Enriched Uranium and is leading the effort to restore America's uranium enrichment capabilities at scale so that we can meet our clean energy, energy security, and national security needs. Find out more at www.centrusenergy.com or follow us on LinkedIn and X.
Forward Looking Statements:
This news release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "will", "should", "could", "would" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions with respect to future events and operational, economic and financial performance.
For Centrus Energy Corp., particular factors that involve uncertainty and could cause our actual future results to differ materially from those expressed in our forward-looking statements and which are, and may be, exacerbated by any worsening of the global business and economic environment include but are not limited to the following: the war in Ukraine and other geopolitical conflicts; our government contracts, including related to changes to the U.S. government's appropriated funding levels for HALEU and the government's inability to satisfy its obligations, and our lease to our facility in Piketon, Ohio; whether or when government demand for HALEU or LEU for government or commercial uses will materialize and at what level; the impact and potential extended duration of a supply/demand imbalance in the market for LEU; significant competition from major LEU producers, including foreign competitors, who may be less cost sensitive than we are; limitations on our ability to compete in foreign markets; pricing trends and demand in the uranium and enrichment markets, especially in light of the potential of limited supply and our dependence on others for deliveries of LEU; and our ability to successfully implement our planned expansion projects in Piketon, Ohio and Oak Ridge, Tennessee.
Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this news release and in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025, under Part II, Item 1A - "Risk Factors" in our Quarterly report on Form 10-Q for the quarter ended March 31, 2026, under Part II, Item 1A - "Risk Factors" in our Quarterly report on Form 10-Q for the quarter ended June 30, 2026, and our filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Meta v pondělí odpoledne vzrostla asi o 1,5 % na 557,875 USD, protože růst reklamy převážil obavy z AI. Tržby ve 2. čtvrtletí vyskočily o 28 % na 60,8 miliardy USD.
Meta Platforms META , the social-media, digital-advertising and artificial-intelligence powerhouse, climbed approximately 1.5% to $557.875 Monday afternoon while semiconductor selling dragged the Nasdaq lower. That divergence matters. Investors were buying Meta's proven AI revenue machine while dumping technology companies carrying heavier expectations.
The numbers explain the confidence. Second-quarter revenue rocketed 28% to $60.8 billion as AI-powered advertising tools lifted engagement and pricing. Then came the gut punch: free cash flow crashed 91% to $784 million as Meta accelerated its infrastructure spending.
At roughly 21 times trailing earnings, Meta remains cheaper than several mega-cap rivals growing more slowly. The valuation gap looks enormous, with the $557.875 share price sitting 33.74% below the $841.91 GF Value™ estimate. But cheap does not mean painless. Capital expenditures are exploding, and a multistate youth-safety trial could force changes to the recommendation systems that keep users scrolling. For now, the advertising engine is winning the argument.
Google podle zprávy přesune výrobu všech zařízení Pixel z Číny do Vietnamu a Indie, a to od roku 2027. Současně chce letos zvýšit dodávky telefonů Pixel o 8 % až 10 %.
Google is reportedly moving forward with shifting all manufacturing of its Pixel devices outside of China starting in 2027.
The tech giant has previously made its Pixel phones, watches and earbuds in China – though that's set to change next year, with Google informing suppliers that the production of those devices will move out of the country into Vietnam and India, according to a report from last week by Nikkei Asia.
The report cited a source who told the outlet that Google will be better-positioned to move production out of China than tech rival Apple because Pixel devices aren't sold directly in the Chinese market, while it's also a relatively small base of smartphone users.
Nikkei Asia previously reported in January that Google was planning to develop and manufacture Pixel 11 devices in Vietnam exclusively, with the process requiring investment in testing equipment as well as tooling machines. According to the latest report, the success of that process prompted Google to expand production for other Pixel devices in Vietnam.
CHINA NARROWS AMERICA'S AI LEAD AS HUAWEI EXPANDS ITS GLOBAL TECH FOOTPRINT, FORMER US OFFICIAL WARNS
Google is reportedly shifting production of its Pixel devices out of China into Vietnam and India. (Michael Nagle/Bloomberg via Getty Images)
Google also reportedly told suppliers that it intends to increase shipments of Pixel phones by 8% to 10% this year after the company shipped 12 million Pixel phones a year ago.
The production boost comes against the backdrop of Google's push to promote consumer usage of its Gemini artificial intelligence (AI) tools.
If Google proceeds with the move, it would follow Samsung in moving smartphone production out of China. Samsung's production shifted out of China in a process that took over a year and concluded in 2019 with most of its manufacturing moving to Vietnam and India.
GOOGLE LAUNCHES GLOBAL STUDY OF MILLIONS OF AI CHATS TO UNDERSTAND HOW PEOPLE USE ARTIFICIAL INTELLIGENCE
Ticker Security Last Change Change % GOOGL ALPHABET INC. 348.06 +3.24 +0.94% The ongoing shortage of memory chips caused by the AI buildout of data centers and cloud services is affecting companies across the tech sector.
Google has reportedly looked to address that issue by combining orders for phone memory chips with those for its AI and cloud businesses.
MODERNA CEO WARNS CHINA IS INVESTING HEAVILY IN MRNA AS BEIJING CHALLENGES US IN BIOTECHNOLOGY
The Google Pixel 11 Pro smartphone is displayed during the "Made by Google" product launch event in New York City on Aug. 12, 2026. (Timothy A. Clary / AFP via Getty Images)
By doing so, the company is able to enhance its negotiating position with major suppliers of memory chips, potentially leading to improved terms for its memory chip purchases across its business lines.
Amazon je letos v plusu 12 % a obchoduje se s P/E 21, což je nejníže za nejméně 10 let. Firma zároveň hlásí backlog 496 miliard USD a ve 2. čtvrtletí zvýšila tržby o 20 %.
Amazon (AMZN +1.33%) stock has trailed the S&P 500 for most of 2026 and is now in line with the large-cap benchmark, up 12% year-to-date.
There are several reasons Amazon's stock has lagged for most of this year, but there is one major reason investors should buy it now in August.
Image source: Getty Images.
Amazon stock is trading at one of its lowest valuations in a long time. Its current P/E ratio is 21, and other than a dip to 19 in June of this year, it hasn't been this low in at least 10 years, but likely much farther back than that.
AMZN PE Ratio data by YCharts
That right there is enough to signal a strong buy on Amazon stock. Any time one of the largest, most successful companies in the world, one of the Magnificent Seven stocks, is trading at a decade-low valuation, the buy sign should be flashing.
In Amazon's case, it is the leader in both of its major markets: e-commerce and cloud computing. It's just a no-brainer buy right now.
A massive $496 billion backlog The dirt cheap valuation is the number one reason to buy, but also, Amazon is heading back in the right direction after a bumpy start to the year.
One of the chief concerns about Amazon was its massive increase in spending on artificial intelligence. At the start of the year, Amazon proposed a whopping $200 billion in capital expenditures to maintain the huge demand for AI infrastructure. That's some 51% more capex spending than in 2025.
Investors balked, as Amazon had been steadily losing market share to Microsoft (MSFT +0.84%) and Google, owned by Alphabet (GOOG +0.83%) (GOOGL +0.94%), so they questioned whether more spending was the answer, particularly given its cash-flow depletion.
But Amazon officials argued that the infrastructure was necessary to regain lost market share and meet demand from its growing backlog of $496 billion in contracts. In fact, CEO Andy Jassy said on the Q2 call that Amazon now projects $220 billion in capex in 2026.
"Even at that amount, we will still not have enough capacity to meet all the demand we have in 2026, and I believe this dynamic will also be true in 2027, too," Jassy said on the call.
Analysts are bullish on Amazon The investments may already be paying off as Amazon reported blowout second-quarter earnings. Amazon Web Services, its cloud computing business, had its fastest growth in more than four years with revenue rising 37%. Overall revenue increased 20%.
Today's Change
(
1.33
%) $
3.44
Current Price
$
262.07
Further, its operating income soared 43% to $27.5 billion while net income increased 243% to $62.6 billion, boosted by its investments in Anthropic.
Amazon anticipates sales to rise 9% to 12% year over year in the third quarter and operating income to be between $22.5 billion and $26.5 billion, up 29% at the midpoint.
That's not quite the growth rate Amazon saw in Q2, but at that low multiple, Amazon stock is just too attractive to pass up with its massive earnings power and growing backlog. Wall Street is almost unanimously in agreement, with 97% of analysts rating it a buy and a median price target of $327 per share. That suggests 27% upside for Amazon stock.
Microsoft v pondělí vzrostl asi o 1,1 % na 488,93 USD, zatímco Nasdaq táhly dolů polovodiče. Čtvrtletní tržby stouply o 18 % na 90 mld. USD a objem komerčních remaining performance obligations vyskočil o 84 % na 678 mld. USD.
Microsoft MSFT , the enterprise-software, cloud and artificial-intelligence powerhouse, climbed approximately 1.1% to $488.93 Monday even as semiconductor stocks dragged the Nasdaq lower. That resilience is no accident. Investors see Microsoft's colossal contracted backlog as a powerful cushion if the technology trade cracks again.
Fiscal fourth-quarter revenue jumped 18% to $90 billion, Azure growth accelerated to 43% and commercial remaining performance obligations exploded 84% to $678 billion. Roughly 30% of those commitments should convert into revenue within 12 months, while Microsoft Cloud revenue advanced 27% to $59.3 billion. The demand is already booked. Now Microsoft must deliver it.
The valuation picture adds fuel to the bull case: Microsoft's $488.93 share price sits 15.51% below its $578.67 GF Value estimate. But the AI buildout carries a brutal price tag. Quarterly capital expenditures topped $41 billion, driving free cash flow down 23% to $19.6 billion. Investors still believe Microsoft can transform aggressive infrastructure spending into durable cash generation, but the widening gap between operating cash flow and free cash flow is the pressure point that cannot be ignored.
AMD v pondělí odpoledne klesla asi o 2,9 % na 459,24 USD, zatímco celý Philadelphia Semiconductor Index byl v červených číslech. Trh teď čeká na hospodářské výsledky Nvidie 26. srpna jako na test celého byznysu s AI čipy.
Advanced Micro Devices AMD , the chipmaker fighting for a bigger slice of the AI boom, tumbled approximately 2.9% to $459.24 Monday afternoon as every stock in the Philadelphia Semiconductor Index turned red. Nvidia's August 26 earnings have become more than one company's report. They are now a stress test for the entire AI-chip trade.
AMD's second-quarter revenue smashed a record $11.5 billion, including roughly $6.7 billion from data centers. OpenAI, Meta and Anthropic have already placed major bets on AMD accelerators. The demand is real. So is the execution risk. Those agreements must survive years of software development, infrastructure spending and large-scale deployment before they become the profit machine investors expect.
Here is the uncomfortable part: the stock trades at roughly 118 times trailing earnings, while its $459.24 market price sits 67.18% above the $274.70 GF Value estimate. That is not a modest premium. It is a towering bet that AMD's MI450 systems will ship fast, scale smoothly and protect margins. Monday's drop sent a sharp warning—Wall Street is finished applauding promises. It wants chips moving, profits climbing and cash pouring in.
Nike potichu zavírá obchody Nike Well Collective; podle Fast Company už skončilo nejméně 24 prodejen ve 12 státech. Uzavírky přicházejí v rámci širší restrukturalizace. V dubnu 2026 sportovní gigant oznámil, že zruší 1 400 pracovních míst, převážně v technologických rolích.
Nike has been quietly shuttering Nike Well Collective stores, its small-format neighborhood shop concept.
At least 24 stores have closed across a dozen states, a Fast Company review has found. The closures appear to be happening alongside a broader restructuring.
In April 2026, the sportswear giant announced it would eliminate 1,400 jobs, primarily technology roles. The brand also said it would consolidate its technology footprint at its headquarters in Oregon and the Nike India Technology Center.
Nike also reportedly closed its boutique-style group fitness studios, Nike Studios, in March 2026. The studios had been part of a three-year experiment in collaboration with FitLab.
Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day
In an earnings call this summer, Elliott Hill, Nike’s CEO, said the company was making changes to its direct-to-consumer strategy, including elevating the user experience.
“We’ve elevated more than 150 stores with sport-led experiences. Over time, we will continue to rezone and elevate our fleet and close the doors that are no longer aligned to our strategy,” Hill said on the call.
How Nike Well Collective got its start Nike Well Collective got its start as a different name and concept. The retailer introduced the Nike Live concept in 2018 with the opening of its first store, Nike by Melrose, in Los Angeles, which has since closed.
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Amy Reinhard, Netflix's advertising president. Katie Jones/Variety via Getty Images Netflix is shaking up its ads leadership.
Jon Whitticom, a prominent Netflix exec who helped build the streamer's advertising business, is leaving the organization, according to a memo viewed by Business Insider.
Advertising president Amy Reinhard shared the news with staff last week, saying she had "decided to part ways" with Whitticom. She added that ads product exec Marc Heneghan would lead the unit on an interim basis while a search is conducted for Whitticom's replacement.
"At Netflix, we expect our leaders to build and maintain trust, share context generously, collaborate cross-functionally, and cultivate an environment where people can do their best work," she wrote. "Jon and I have discussed these needs directly over time, and my decision reflects this standard now and going forward."
The ads business is one of the key levers Netflix is leaning on for growth, along with live sports and creator content, as Wall Street worries about the streamer's US engagement growth slowing. The company said this year that in countries where it offers an ads tier, more than 60% of new subscribers choose its cheaper, ad-supported plan.
Alex Schultz talks about Meta Ray-Ban Glasses and its 'big breakthrough' with the SuperBowl
Whitticom, Netflix's VP of ads product, started as an ad platform advisor in early 2023. His appointment was closely watched because of its potential to help Netflix decide how to level up its then-nascent advertising business. He previously was chief product officer at Comcast-owned ad startup FreeWheel.
Under Whitticom, Netflix built out its ad tech and enabled advertisers to buy its ads through other companies like Google, The Trade Desk, and Magnite. The buildout has also had bumps along the way, with multiple leadership changes and competing internal visions over how to grow the business.
"Speed got us from zero to one," Reinhard wrote in her memo. "Getting to what's next means knowing when to move fast and how to do it together."
Netflix has said it expects to hit $3 billion in ad revenue this year, nearly doubling its 2025 haul. The company is also introducing new ad formats and expanded ways for advertisers to buy inventory, Reinhard said in an announcement concluding its Upfront sales process, where TV companies pitch big advertisers for extensive ad deals.
Here's the full memo from Reinhard:
Team,I wanted to let you know about a leadership change I'm making to better reflect the needs of the business and the growth ahead in Ads.After careful consideration, I've decided to part ways with Jon Whitticom, and today will be his last day. Jon helped build Ads Product from the ground up and led the launch of the Netflix Ads Suite last year, a major milestone for our business and Netflix. I'm grateful for all his contributions over the past two-plus years.At Netflix, we expect our leaders to build and maintain trust, share context generously, collaborate cross-functionally, and cultivate an environment where people can do their best work. Jon and I have discussed these needs directly over time, and my decision reflects this standard now and going forward. Speed got us from zero to one. Getting to what's next means knowing when to move fast and how to do it together.Marc Heneghan will lead Ads Product on an interim basis while I immediately begin an external search for a new leader. All of Jon's directs will now report to Marc.There's never a good moment for a change like this; I know it often carries risk and disruption. But I also know this team is resilient and our foundation is strong. What isn't changing are our priorities as a business, or my confidence in this team's ability to stay focused on the bigger picture and maintain our momentum on our near-term deliverables.I will host separate sessions with the Ads Product team and the Ads Platform teams to talk through our path forward and answer any questions. Those teams should look out for a calendar invite to join a session.Please join me in thanking Jon and wishing him the best in the future.Best,Amy
Read next
Lucia Moses You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Lucia Moses covers the media and entertainment business, with a focus on how creators build businesses, how media companies intersect with creators, and how marketers adopt entertainment tools. She's broken stories about MrBeast's ambitions, Google's movie initiative, and Netflix's push into podcasts.She previously reported on media and managed teams at Digiday and Adweek.
Mastercard v pondělí odpoledne vzrostl asi o 2,7 % na 596,315 USD, protože investoři mířili do finančních titulů. Čisté tržby za 2. čtvrtletí stouply o 14 % na 9,28 miliardy USD.
, the global payments and financial-technology powerhouse, jumped approximately 2.7% to $596.315 Monday afternoon as money rushed into financial stocks and fled collapsing semiconductor names. The shares came within striking distance of their $598.34 session high. Buyers were not nibbling. They were pressing.
The numbers explain why. Second-quarter net revenue climbed 14% to $9.28 billion, while adjusted operating income powered 16% higher to $5.67 billion. Cross-border volume increased 12%. Value-added services revenue surged 18%. Mastercard is no longer riding transaction growth alone—it is building another serious profit engine around the network.
The model remains brutally attractive. Mastercard does not lend consumers money or fill warehouses with inventory. It collects a toll whenever money moves. The picture strengthens the bull case: the $596.315 share price stands 11.81% below the $676.18 GF Value™, leaving a meaningful valuation gap even after Monday's rally. But at roughly 33 times earnings, there is no room for a stumble. Double-digit growth must continue as stablecoins, instant bank transfers and regulators attack from every direction.
, the world's largest electronic-payments network, surged roughly 2.4% to $380.2511 Monday afternoon as financial stocks pulled the Dow higher. The shares hit $381.91 during the session, punching deeper into record territory while the Nasdaq stumbled.
The numbers explain the confidence. Fiscal third-quarter revenue jumped 14% to $11.6 billion, while adjusted net income landed at $6.3 billion. Payments volume rose 10%. Processed transactions rose 10%. Cross-border volume excluding Europe climbed another 12%. More spending, more transactions, more fees flowing through Visa's machine.
Visa does not need expensive factories or billion-dollar bets on the next chip cycle. It gets paid whenever money moves across its network. The chart shows the stock trading 9.95% below its $422.27 GF Value estimate, suggesting room beyond the latest record run. But at roughly 32 times earnings, perfection is already expensive—and weaker consumer spending or tougher merchant-fee regulation could quickly test that premium.
JPMorgan Chase v druhém čtvrtletí vykázala čistý zisk 21,2 miliardy USD při upravených tržbách 58 miliard USD. Tržby z trhů vzrostly o 35 % na 12,1 miliardy USD.
, America's largest bank by assets, jumped approximately 0.9% to $354.84 Monday afternoon as financial stocks carried the Dow while technology shares cracked. Lower long-term Treasury yields also took some heat off bond portfolios and borrowing conditions.
The bank's engine is firing on every cylinder. Second-quarter net income reached $21.2 billion on $58 billion of managed revenue. Markets revenue ripped 35% higher to $12.1 billion, powered by an 86% explosion in equity-markets revenue to $6 billion. Net interest income climbed another 10% to $25.6 billion.
That is the JPMorgan advantage: chaos can become revenue. Trading desks feast on volatility, deposits provide cheap funding and lending keeps the cash machine running. But investors are already paying for that firepower. The $354.84 share price stands 12.98% above the $314.07 GF Value™ estimate, while the stock trades near 15 times earnings. JPMorgan may be the strongest house on the banking block, but this price leaves little room for a cracked consumer, stalled dealmaking or an earnings stumble.
FDA rozšířil schválení léku J&J Imaavy pro vzácnou krevní poruchu wAIHA u pacientů od 12 let, kteří jsou aktuálně nebo dříve léčeni steroidy. Je to první léčba pro toto onemocnění.
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's (JNJ.N) drug to treat a rare blood disorder, the company said on Monday.
The approval makes Imaavy the first treatment cleared for warm autoimmune hemolytic anemia, or wAIHA, and covers patients aged 12 and older who are currently or were previously treated with steroids.
The life-threatening disease causes the immune system to destroy red blood cells, leading to severe anemia, fatigue, blood clots and kidney failure.
Imaavy blocks a protein that keeps harmful antibodies in the bloodstream, lowering their levels while preserving other immune functions. The drug is infused into a vein every four weeks at a dose based on weight.
"Imaavy was able to demonstrate patients can go down on their steroids and still maintain that clinical response. Those are really important advances for patients," Johnson & Johnson's global immunology head David Lee told Reuters.
The approval was based on a mid-to-late-stage study of 115 adults in which about three times as many patients receiving Imaavy achieved a lasting improvement in hemoglobin levels after 24 weeks as those on placebo. Hemoglobin carries oxygen in red blood cells.
The most common side effects were swelling in the arms or legs, diarrhea and fever. Imaavy can also raise the risk of infections and cause serious allergic or infusion-related reactions, according to its prescribing information.
Lee said existing treatments also have toxicities and may not adequately control the disease. He said Imaavy improved and stabilized patients' blood counts in the study.
About one in 8,000 people have wAIHA, with one to three new cases diagnosed annually per 100,000 people, according to Johnson & Johnson.
Imaavy was first approved in April last year to treat generalized myasthenia gravis in certain adults and patients aged 12 and older. The rare immune disorder causes muscle weakness.
ExxonMobil je jedním ze čtyř uchazečů o americká chemická aktiva Shell, jejichž cena může dosáhnout až 8 miliard USD. Případná koupě by výrazně rozšířila jeho petrochemické podnikání v USA.
Shell (SHEL -0.35%) has received interest from multiple bidders for its U.S. chemicals assets, including ExxonMobil (XOM -0.64%). According to a Financial Times report, Exxon is among the four remaining bidders for the assets, which could cost up to $8 billion. They're non-binding bids that represented various expressions of interest in these assets.
Here's a look at what it would mean for ExxonMobil investors if the energy giant won the bidding for Shell's U.S. chemicals assets.
Image source: Getty Images.
Drilling down into the potential saleShell is looking to divest some of its underperforming assets, which include its U.S. chemical plants. The global energy giant currently operates four plants in the U.S. across Louisiana, Texas, and Pennsylvania. They produce chemicals used in plastics, detergents, and pharmaceuticals.
According to the Financial Times, four entities have submitted bids for these assets: ExxonMobil, the chemicals company LyondellBasell, the private equity firm Apollo Global Management, and the chemicals arm of the state-owned Kuwait Petroleum Corporation. Some of those bids were for the entire portfolio, while others were for only some of the assets.
Today's Change
(
-0.35
%) $
-0.33
Current Price
$
93.00
The reported $8 billion potential price tag represents a steep discount to Shell's invested capital in the assets, driven by underperformance and the current cyclical downturn in the chemicals sector. Shell spent $14 billion alone to build its Pennsylvania plant, more than double the initial cost estimate. It has had operational and financial troubles since opening. The overall headwinds affecting its chemicals business have weighed on Shell's earnings in recent years, though improved chemicals margins in the second quarter of this year helped boost earnings.
A sale of its underperforming U.S. chemicals assets would enable Shell to sharpen its focus on its best assets. It recently agreed to sell its onshore European renewables platform to TotalEnergies.
What a winning bid would mean for ExxonMobilIf Exxon wins the bidding for Shell's U.S. chemicals assets, it would significantly expand the U.S. energy giant's domestic petrochemical footprint. That would enhance its scale advantages, enabling it to leverage its greater scale to get more out of these assets. A core aspect of Exxon's long-term strategy is delivering structural cost savings, which it could enhance by acquiring assets that would increase its scale and enable operational synergies. Further, it would do so at a significant discount to replacement cost. It would be buying assets near the cycle's low point, which is ideal timing because it would enable the company to capitalize on the next cyclical recovery and expansion.
Today's Change
(
-0.64
%) $
-1.06
Current Price
$
164.05
A deal for Shell's U.S. chemicals assets would also enable ExxonMobil to continue to diversify beyond oil and gas. Exxon already has a meaningful product solutions portfolio (energy, chemical, and specialty products) that it's investing heavily to expand, including new products like Proxxima. Exxon currently aims to deliver $9 billion in earnings growth from its product solutions businesses by 2030, at constant margins relative to 2024, driven by investments to expand its high-margin products and achieve structural cost savings.
A potential deal looks like a good strategic fitExxonMobil is reportedly one of four bidders for Shell's chemicals assets. It might not emerge as the winning bidder, given the competition. It's also possible that even if it has the highest bid, Shell opts to hold on to the assets in hopes that the continued recovery in the chemicals market will enable it to fetch a higher price in the future.
However, if Exxon wins the bidding, it looks like a very smart strategic acquisition. It would meaningfully expand its domestic chemicals business at an attractive price. That greater scale would provide opportunities to capture synergies that could make its entire chemicals business even more profitable in the future. That makes this potential deal an interesting one for ExxonMobil investors to keep an eye on, as it could further enhance the already strong long-term investment thesis that makes it a top oil stock to buy.
Akcie Oracle v poslední obchodní seanci klesly o 2,74 % na 142,45 USD, ale za poslední měsíc jsou stále výše o 27,38 %. Před výsledky se čeká EPS 1,72 USD a výnosy 19,14 miliardy USD.
Oracle (ORCL - Free Report) closed the most recent trading day at $142.45, moving -2.74% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.28%. At the same time, the Dow added 0.26%, and the tech-heavy Nasdaq lost 0.77%.
Shares of the software maker have appreciated by 27.38% over the course of the past month, outperforming the Computer and Technology sector's gain of 1.04%, and the S&P 500's gain of 2.31%.
The upcoming earnings release of Oracle will be of great interest to investors. The company is predicted to post an EPS of $1.72, indicating a 17.01% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $19.14 billion, up 28.24% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $8.03 per share and a revenue of $89.8 billion, indicating changes of +5.24% and +33.32%, respectively, from the former year.
It is also important to note the recent changes to analyst estimates for Oracle. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.27% upward. Oracle currently has a Zacks Rank of #2 (Buy).
Looking at valuation, Oracle is presently trading at a Forward P/E ratio of 18.23. This valuation marks a premium compared to its industry average Forward P/E of 17.72.
We can also see that ORCL currently has a PEG ratio of 0.74. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Computer - Software industry stood at 1.56 at the close of the market yesterday.
The Computer - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 96, this industry ranks in the top 40% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
TSMC v pondělí ráno klesla o 2,3 % kvůli výprodeji čipů, i když červencové výnosy meziročně vyskočily o 44,7 % na NT$467,58 miliardy. Investoři teď čekají, zda Nvidia 26. srpna potvrdí silnou poptávku.
Taiwan Semiconductor Manufacturing TSM , the world's largest contract chipmaker, slid approximately 2.3% to $409.41 Monday morning as the chip selloff spread fast. Samsung Electronics SSNLF crashed 9%. Micron MU and SK Hynix HXSCL sank with it. Investors were not waiting for Nvidia's next update—they were cutting risk first.
But TSMC's growth engine is still running red-hot. July revenue surged 44.7% year over year to NT$467.58 billion. Management has raised its 2026 capital-spending plan to between $60 billion and $64 billion as Nvidia, Apple, AMD, Broadcom and major cloud operators scramble for leading-edge capacity. Demand is huge. So is the bet.
Now Nvidia NVDA holds the match. A powerful August 26 outlook would make TSMC's expansion look perfectly timed. Any hint of cooling orders would make those enormous fabrication commitments look far more dangerous. The valuation leaves little room for disappointment: at $409.41, the stock trades 15.47% above its $354.56 GF Value estimate. Monday's decline was not a demand collapse. It was a warning that investors want Nvidia to justify every dollar of that premium.
The Trade Desk Inc (NASDAQ:TTD) shares are trading lower in Monday’s after-hours session after the company filed a prospectus for a mixed shelf offering.
Trade Desk stock is showing downward bias. What’s ahead for TTD stock? The Trade Desk Files For OfferingThe Trade Desk filed with the SEC on Monday to potentially offer and sell common stock, preferred stock, debt securities, warrants or units from time to time in one or more offerings.
Terms and size of the offering were not disclosed. A prospectus supplement would need to be filed each time the company or any selling stockholders decides to offer and sell any securities.
The Trade Desk had approximately $1.12 billion in total cash and cash equivalents as of June 30.
TTD Shares Move LowerTTD Price Action: The Trade Desk shares were down 2.13% in after-hours, trading at $12.99 at the time of publication on Monday, according to Benzinga Pro. The stock is down approximately 65% year-to-date and is trading near 52-week lows of $12.83 reached in early August.
Read Next
Image: Shutterstock.com
Market News and Data brought to you by Benzinga APIs
McKesson zvýšil výhled upraveného zisku na akcii pro fiskální rok 2027 na 44,20–45,00 USD, tedy o 13 % až 15 %. Zároveň plánuje asi 5 mld. USD zpětných odkupů a zvýšil čtvrtletní dividendu o 15 % na 94 centů.
Key Takeaways McKesson targets 13%-15% fiscal 2027 adjusted EPS growth as specialty businesses expand.MCK trades at 18.4X forward earnings, above its five-year median of 15.7X and sub-industry's 17.6X.McKesson plans about $5B in fiscal 2027 buybacks and raised its quarterly dividend 15% to 94 cents. McKesson Corporation (MCK - Free Report) enters fiscal 2027 with double-digit earnings growth, faster expansion in specialty businesses and sizable capital returns. Those strengths support the long-term case, but the shares now trade above important historical and industry valuation benchmarks.
That leaves investors with a tighter decision. The operating story is improving, yet the current multiple leaves less room for execution misses, policy changes or a slowdown in earnings momentum.
McKesson's Growth Case Remains StrongMcKesson raised fiscal 2027 adjusted earnings guidance to $44.20-$45.00 per share, implying 13%-15% growth. Management also continues to target long-term adjusted earnings growth of 13%-16%, supported by organic growth, operating leverage and capital allocation.
The mix is moving toward higher-growth specialty platforms. First-quarter Oncology & Multispecialty revenues increased 33% and adjusted operating profit rose 41%, while Prescription Technology Solutions operating profit advanced 13%. The U.S. Oncology Network now includes about 3,400 providers and treats more than 2 million patients annually.
Cencora, Inc. (COR - Free Report) provides a useful industry reference point. It reported 5.1% revenue growth in its fiscal 2026 third quarter and raised full-year adjusted earnings guidance, showing that pharmaceutical distribution and specialty exposure continue to support growth across the group.
MCK's Premium Valuation Limits the Margin for ErrorMcKesson trades at 18.4X forward 12-month earnings, above its five-year median of 15.7X and the Zacks sub-industry multiple of 17.6X. The current valuation remains below its five-year high of 22.8X, but it already prices in a meaningful portion of the earnings-growth story.
That premium raises the importance of consistent execution. Cardinal Health, Inc. (CAH - Free Report) , another major pharmaceutical and specialty distributor, underscores the competitive scale of the sector. Investors paying above McKesson's historical median will likely want continued specialty growth and operating leverage to justify the higher multiple.
Image Source: Zacks Investment Research
McKesson's Capital Returns Support Per-Share GrowthMcKesson repurchased $2.5 billion of stock in the first quarter, including $2.25 billion through an accelerated program. Full-year guidance anticipates about $5 billion of repurchases, reinforcing management's commitment to returning excess capital.
The board also raised the quarterly dividend 15% to 94 cents per share. McKesson expects diluted weighted-average shares of 115.5 million to 117.5 million for fiscal 2027, down from 124.1 million in fiscal 2026, which should continue to support per-share earnings growth.
MCK Still Faces Concentration and Policy RisksCustomer concentration remains a material risk. McKesson's 10 largest customers accounted for about 73% of fiscal 2026 consolidated revenues, while its largest customer represented roughly 24%. That exposure increases sensitivity to contract renewals, purchasing changes and service requirements.
Policy uncertainty adds another layer. Drug-pricing and reimbursement changes, 340B developments and manufacturer contracting behavior can affect revenue presentation, service fees and customer economics. Separation-related financing for Medical-Surgical Solutions also increases interest expense and adds execution complexity.
McKesson's Hold Signal Balances the Trade-OffThe bottom line is that McKesson's growth profile remains attractive, but the valuation offers less margin for error than it did at its historical median. The combination favors patience over chasing the shares after a strong rerating.
MCK currently carries a Zacks Rank #3 (Hold), along with a Value Score of A, Growth Score of A, Momentum Score of A and VGM Score of A. The Style Scores point to favorable characteristics across several investment approaches, but they are designed to complement the Zacks Rank. With a Hold rank, the stock may remain suitable for existing holders, while prospective buyers have reason to weigh valuation and execution risk before committing new capital. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Hub Group obdržel 20. srpna 2026 od Nasdaq upozornění na nesoulad kvůli opožděnému podání formuláře 10-Q za čtvrtletí končící 30. června 2026. Na obchodování akcií to nemá okamžitý dopad.
OAK BROOK, Ill., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (Nasdaq: HUBG) today announced that on August 20, 2026, as expected, it received a notice indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Form 10-Q for the quarter ended June 30, 2026 (the “Form 10-Q”). The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.
The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.
About Hub Group
Hub Group offers comprehensive transportation and logistics management solutions. Keeping our customers’ needs in focus, Hub Group designs, continually optimizes, and applies industry-leading technology to our customers’ supply chains for better service, greater efficiency, and total visibility. As an award-winning, publicly traded company (Nasdaq: HUBG), our approximately 6,000 employees and drivers across the globe are always in pursuit of “The Way Ahead” – a commitment to service, integrity and innovation. For more information, visit hubgroup.com.
Merit Medical zvýšil výhled tržeb i upraveného zisku na akcii pro rok 2026 po silnějších výsledcích za první pololetí. Akcie MMSI se ale dál obchodují za 20,3násobek forward P/E, nad 17,6násobkem v pododvětví.
Key Takeaways Merit Medical raised its 2026 revenue and adjusted earnings outlook after stronger first-half results.Therapeutic products are projected to grow 9.1% from 2025-2028, versus 4.7% for Foundational products.Merit Medical trades at 20.3X forward earnings versus 17.6X for its sub-industry, raising execution pressure. Merit Medical Systems, Inc. (MMSI - Free Report) is showing a better operating trajectory as therapeutic products, recent launches and acquisitions broaden its growth mix. Earnings expectations have also improved, strengthening the fundamental case.
The trade-off is valuation. MMSI still carries a premium to its Zacks sub-industry, leaving less room for execution misses even as its growth outlook becomes more favorable.
Merit Medical’s Growth Case Is Getting StrongerFor 2026, the Zacks model projects revenues and adjusted earnings per share to increase 7.6% and 11.5%, respectively. The company also raised its 2026 revenue and adjusted earnings outlook after stronger-than-expected first-half results.
From 2025 through 2028, revenues and adjusted earnings are projected to post compound annual growth rates of 6.2% and 8.9%, respectively. Therapeutic products are expected to grow at a 9.1% rate, ahead of 4.7% for Foundational products, improving the mix toward faster-growing categories.
Image Source: Zacks Investment Research
MMSI’s Valuation Leaves Less Room for ErrorMMSI trades at 20.3X forward 12-month earnings compared with 17.6X for its Zacks sub-industry. That premium means further upside depends more heavily on sustained revenue growth, margin execution and continued earnings delivery.
The multiple is below MMSI's five-year median of 24.5X, which tempers the valuation concern. Still, the stock is not inexpensive relative to its sub-industry, so stronger fundamentals need to translate into consistent results.
Image Source: Zacks Investment Research
New MMSI Platforms Add Longer-Term OptionalityThe View Point Medical acquisition added the OneMark Detection Imaging System and OneMark Tissue Markers to Merit Medical's oncology portfolio. Combined with the late-May launch of SCOUT MD, the technologies broaden breast-care localization options across diagnosis and surgery.
Endoscopy also gained the Resilience Through-the-Scope Esophageal Stent and C2 CryoBalloon. WRAPSODY remains a multi-year renal-therapy opportunity, although the unchanged $7 million U.S. revenue assumption for 2026 keeps near-term expectations measured.
Image Source: Zacks Investment Research
Merit Medical Faces Tariff and Execution RisksManagement now expects a 2026 tariff burden of approximately $16 million, or 21 cents per share, up from its prior assumption. Buyer consolidation, distributor dependence in some international markets and currency volatility can also pressure pricing and visibility.
Competition remains broad. Boston Scientific Corporation (BSX - Free Report) operates across endoscopy and cardiovascular devices, creating overlap with several Merit Medical procedure areas. Medtronic plc (MDT - Free Report) also reports Cardiovascular and Surgical & Endoscopy businesses, underscoring the need for Merit Medical to support launches while defending established positions.
MMSI’s Balance Sheet Supports Strategic FlexibilityMerit Medical ended the second quarter with $448.7 million in cash and cash equivalents and $736.3 million in long-term debt. Its debt-to-capital ratio was 30.5%, below the industry level of 50.5%.
Management is building an M&A playbook and broader capital-allocation framework as part of its 2027-2029 strategic planning process. That liquidity can support potential tuck-in acquisitions and product-pipeline priorities, although deployment discipline remains important.
MMSI Signals Support a Patient StanceMMSI's improving growth mix, portfolio expansion and stronger earnings outlook support the fundamental case, but the valuation premium and execution risks argue against treating the setup as an easy decision. The balance remains constructive rather than decisive.
The stock currently carries a Zacks Rank #3 (Hold). Its Momentum Score of A and VGM Score of B are favorable, while its Value Score of C and Growth Score of C are more middle-of-the-pack. Taken together, the signals support patience while investors watch whether execution can justify the premium. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Weatherford a NCS Multistage oznámily, že akcionáři NCS Multistage musí provést volbu protihodnoty fúze do 31. srpna 2026. Uzavření transakce se očekává kolem 1. září 2026.
HOUSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford”) and NCS Multistage Holdings, Inc. (NASDAQ: NCSM) (“NCS Multistage”) today announced that 5:00 P.M., Eastern Time on August 31, 2026 is the anticipated deadline for NCS Multistage stockholders to elect the form of merger consideration that they would be entitled to receive at the closing of the transaction (the “Election Deadline”).
Under the terms of the merger agreement, NCS Multistage stockholders can elect to receive either (i) 0.554 Weatherford ordinary shares at closing (the “Share Consideration”), or (ii) a combination of 0.239 Weatherford ordinary shares and a cash amount equal to 0.137 Weatherford ordinary shares, subject to proration and certain limitations and adjustments.
Holders of NCS Multistage common stock who elect to receive Share Consideration or who do not timely make a valid election before the Election Deadline will be deemed to have elected to receive the Share Consideration, which is not subject to proration or limitations and adjustments.
In connection with NCS Multistage’s mailing of the information statement / prospectus regarding the transaction, record holders of NCS Multistage common stock received an election form and instructions to complete the election form.
The transaction has been approved by the Board of Directors of Weatherford, the Board of Directors of NCS Multistage and the controlling stockholder of NCS Multistage that owns more than 50% of NCS Multistage’s outstanding common stock. The transaction is subject to certain customary closing conditions and is expected to close on or about September 1, 2026 (the “Anticipated Closing Date”). If the transaction does not close by the Anticipated Closing Date, the Election Deadline may be extended. If such an extension occurs, Weatherford and NCS Multistage expect to make an announcement to that effect.
Until the transaction closes, Weatherford and NCS Multistage will continue to operate as separate, independent companies.
About Weatherford
Weatherford is a global energy services company that helps customers drill smarter, complete wells more effectively, and maximize production across the entire well lifecycle. With a differentiated portfolio of market-leading solutions, integrated technologies, and a broad global customer footprint across six continents, we blend advanced engineering, digital intelligence, and world-class field expertise to reduce risk, improve performance, and maximize the value of customer assets. Together, we elevate every operation, delivering stronger wells, sharper decisions, and better energy for the world. Visit weatherford.com for more information and connect with us on social media.
About NCS Multistage
NCS Multistage is a leading provider of highly engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion and field development strategies. NCS Multistage provides products and services primarily to exploration and production companies for use in onshore and offshore wells, predominantly those that have been drilled with horizontal laterals in both unconventional and conventional oil and natural gas formations. NCS Multistage’s products and services are utilized in oil and natural gas basins throughout North America and in selected international markets, including the North Sea, the Middle East and Argentina. Visit ncsmultistage.com for more information.
Forward-Looking Statements
This communication includes statements, which, to the extent they are not statements of historical or present fact, constitute “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements, and any related oral statements, can be identified by the use of terms such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “outlook,” “budget,” “intend,” “strategy,” “plan,” “guidance,” “may,” “should,” “could,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions, although not all forward-looking statements contain these identifying words. These statements include, but are not limited to, statements about the expected timing and completion of the proposed transaction between Weatherford and NCS Multistage, the anticipated benefits of the proposed transaction, and plans and expectations for the new combined company after the completion of the proposed transaction. Such statements are based upon the current beliefs of Weatherford’s and NCS Multistage’s management and are subject to significant risks, assumptions, and uncertainties. Should one or more of these risks or uncertainties materialize, or underlying assumptions prove incorrect, actual results may vary materially from those indicated in our forward-looking statements. Readers are cautioned that forward-looking statements are only estimates and may differ materially from actual future events or results, based on factors including but not limited to the ability to complete the proposed transaction on the timeframe or on the terms currently anticipated or at all, including the risk that the proposed transaction may not be completed in a timely manner or at all; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement; the satisfaction of the conditions precedent to completion of the proposed transaction, including the ability to secure regulatory approvals on the terms expected, at all or in a timely manner; unexpected costs, charges, or expenses resulting from the proposed transaction; the effect of the proposed transaction on the ability to maintain relationships with customers, suppliers, and other business partners or operating results and business; the ability to implement plans, achieve forecasts and meet other expectations with respect to the business after the completion of the proposed transaction and realize expected synergies; business disruption following the proposed transaction; difficulties in retaining and hiring key personnel and employees due to the proposed transaction; the diversion of management time on transaction-related issues; the outcome of any legal proceedings related to the proposed transaction; the ability of Weatherford to successfully integrate NCS Multistage’s operations; cyber-attacks, information security and data privacy; global political and economic conditions, including rising interest rates, the impact of inflation and challenges in the global supply chain; events and trends on a national, regional, and global scale, including the demand for the services provided by NCS Multistage and Weatherford due to levels of employment and economic activity, and those of a political, economic, business, competitive, and regulatory nature; the timing and impact of the proposed redomestication, including, but not limited to, the timing of the completion of the proposed redomestication in relation to the timing of the closing of the proposed transaction and its resulting impact; global political, economic and market conditions, political disturbances, war or other global conflicts, terrorist attacks, public health issues such as pandemics, changes in global trade policies, tariffs and sanctions, weak local economic conditions and international currency fluctuations; general global economic repercussions related to U.S. and global inflationary pressures and potential recessionary concerns; as well as the factors and risks described in Weatherford’s Annual Report on Form 10-K for the year ended December 31, 2025, its definitive proxy statement on Schedule 14A filed with the SEC on July 13, 2026 and its information statement/prospectus filed on July 22, 2026, and NCS Multistage’s Annual Report on Form 10-K for the year ended December 31, 2025, and, in each case, any subsequent Quarterly Reports on Form 10-Q and in other subsequent filings with the U.S. Securities and Exchange Commission. Other unpredictable factors not discussed in this communication could also have material adverse effects on forward-looking statements. You should not place undue reliance on any of Weatherford’s or NCS Multistage’s forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and Weatherford and NCS Multistage undertake no obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law, and we caution you not to rely on them unduly.
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”), or in a transaction exempt from the registration requirements of the Securities Act.
Additional Information About the Transaction and Where to Find It
In connection with the proposed transaction, Weatherford filed a registration statement on Form S-4 (the “Form S-4”) that also constitutes a prospectus of Weatherford with respect to the shares of Weatherford to be issued in the proposed transaction (the “prospectus”) and NCS Multistage has filed an information statement on Schedule 14C, with the Securities and Exchange Commission (the “SEC”) and mailed that information statement to NCS Multistage stockholders. Each of Weatherford and NCS Multistage may also file other relevant documents with the SEC regarding the proposed transaction. This document is not a substitute for the Form S-4, prospectus, the information statement or any other document that Weatherford or NCS Multistage may file with the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE INFORMATION STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders can obtain free copies of the Form S-4 and the information statement/prospectus and other documents containing important information about Weatherford, NCS Multistage and the proposed transaction through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with, or furnished to, the SEC by Weatherford will be available free of charge on Weatherford’s website at https://weatherford.com/investor-relations/home. Copies of the documents filed with, or furnished to, the SEC by NCS Multistage are available free of charge on NCS Multistage’s website at https://ir.ncsmultistage.com. The information included on, or accessible through, Weatherford’s or NCS Multistage’s website is not incorporated by reference into this communication.
For Investors:
Luke Lemoine
Weatherford Investor Relations
+1 713-836-7777 [email protected]
Mike Morrison
NCS Multistage Holdings Chief Financial Officer and Treasurer
+1 281-453-2222 [email protected]
AeroVironment plánuje investovat 100 milionů USD do nového kampusu v Moorparku v Kalifornii, který sjednotí pět pronajatých lokalit. Akcie v pondělí klesly o 6,70 %.
AeroVironment Inc. (NASDAQ:AVAV) shares are dipping Monday after the company announced plans for a $100 million investment in a new, company-owned campus in Moorpark, California. Here’s what you should know.
AeroVironment shares are retreating from recent levels. Why are AVAV shares down? AeroVironment to Consolidate California Operations Into New CampusAeroVironment said it plans to build a unified campus on roughly 20 acres in Moorpark, bringing together teams and capabilities currently spread across five leased Southern California locations. The company said consolidating those sites into one location would strengthen collaboration across research, engineering, design, prototyping and production.
CEO Wahid Nawabi pointed to the investment as proof that California remains central to AeroVironment’s identity more than 50 years after its founding there. He described the new campus as one designed from the ground up around how employees actually get their work done, with an emphasis on adaptable spaces that let people concentrate, collaborate on technical problems and scale up as the business grows, all while the company channels fresh money into its labs, production lines and workforce.
Chief Operating Officer Rob Smith tied the project to speed, saying the real payoff is how much faster ideas can turn into finished systems delivered to military end users, along with the added capability that comes from that acceleration. He said pulling everything under one roof eliminates the drag that comes from juggling several separate sites, replacing it with a single setting built to move quickly, foster teamwork and scale.
New Campus Adds to AeroVironment’s National Manufacturing FootprintBeyond its impact on California operations, AeroVironment framed the campus as part of a larger manufacturing strategy. The company said the Moorpark investment builds on its broader national manufacturing network, adding resilience to help meet growing demand from U.S. and allied government customers.
Renovation and construction work is expected to begin in fiscal 2028, with employees transitioning to the new campus in phases and the site expected to be fully operational in 2029.
AeroVironment’s Chart Remains Stuck in a DowntrendThe campus news lands on a stock that was already struggling technically before today’s decline. Shares are trading well beneath every major trend line that matters, running 12.3% below the 20-day average, 7.2% below the 50-day average, 13.5% below the 100-day average and 32.1% below the 200-day average. The 20-day average sitting above the 50-day average offers a small near-term positive, but a death cross from March, when the 50-day average dropped below the 200-day, keeps any bounce looking like a counter-trend move rather than a genuine reversal until proven otherwise.
Momentum readings aren’t offering much encouragement either. The MACD line sits below its signal line with a negative histogram, a combination that typically means sellers have the upper hand unless the stock can quickly climb back above its key averages.
The stock’s positioning within its own 52-week range tells a similar story. Shares sit much closer to their 52-week low of $135.20 than their 52-week high of $417.86, which is why traders are focused more on where support might hold rather than where the stock could rally to next. The most recent swing low came in June, and the question now is whether the current slide pushes the stock back down to retest that level.
Resistance sits at $162.50, close to the 50-day average around $161, an area where past rallies have lost steam. Support sits at $140.50, near the lower end of the stock’s 52-week range, a zone where buyers have stepped in before.
AVAV Shares Are FallingAVAV Price Action: AeroVironment shares were down 6.70% at $149.49 at the time of publication on Monday, according to Benzinga Pro.
AMN Healthcare od začátku roku vzrostla o 118,7 % díky silnější poptávce po personálních službách. Ve 2. čtvrtletí výnosy stouply o 2,3 % na 673 mil. USD a upravený zisk na akcii (EPS) vyskočil o 158 % na 77 centů.
Key Takeaways AMN Healthcare has rallied 118.7% YTD as Q2 revenues rose 2.3% and adjusted EPS surged 158%.AMN saw travel nurse orders rise about 40% year over year by early August as staffing demand strengthened.AMN's automation, AI recruiting and high fill rates are helping capture demand amid workforce shortages. AMN Healthcare Services (AMN - Free Report) stock has jumped 118.7% year to date, significantly outperforming its industry’s 10.9% gain and the S&P 500’s 11.7% growth. The rally reflects improving demand across staffing businesses, stronger execution and growing confidence in AMN’s ability to benefit from persistent healthcare workforce shortages.
Second-quarter performance provided a meaningful catalyst, with revenues rising 2.3% year over year to $673 million, 6% above the high end of guidance. Adjusted EPS jumped to 77 cents, up 158% year over year. Nurse and Allied Solutions revenues rose 11%, supported by stronger travel nurse and allied volumes, while search revenue increased 27%.
Image Source: Zacks Investment Research
What Is Fueling AMN’s Growth?Nurse and Allied Demand Is Showing a Strong Rebound: AMN’s core staffing businesses are benefiting from a broad-based recovery in demand. Travel nurse volume increased 6% and allied volume rose 7% in the second quarter, marking the strongest growth rates for both businesses in four years. Travel nurse orders turned positive in May and accelerated in June, with orders up about 40% year over year by early August. Third-quarter guidance calls for more than 10% volume growth in both travel nurse and allied, supporting continued momentum.
Technology and High Fill Rates Are Strengthening Execution: AMN is increasingly using automation, 24/7 operations and AI-enabled recruiting to capture higher demand. These capabilities have improved fill rates across MSP, VMS and third-party platforms, helping the company gain share as demand recovers. Its Passport clinician app surpassed 400,000 users, up 33% year over year, while monthly active users increased more than 50%.
Persistent Workforce Shortages Support Long-Term Demand: AMN’s latest workforce report points to structural staffing pressure extending through 2030. Aging demographics, chronic disease, physician shortages, rural staffing gaps and strong allied-health demand are expected to keep healthcare organizations reliant on flexible and optimized workforce solutions. The report also found that RN supply is not keeping pace with demand, while CT technologist demand has more than doubled since 2021. These trends could support demand for AMN’s nursing, allied health, physician and workforce optimization solutions.
Strategic Acquisitions Expand AMN’s Opportunity: AMN is expanding its capabilities through targeted acquisitions. The company acquired ESSENTIAL Brand Leadership Assessment and Jaide Health. Jaide Health strengthens the company’s AI-enabled language access offerings across the patient journey, while the ESSENTIAL Leadership Assessment broadens its leadership advisory, evaluation and succession-planning capabilities. These additions should deepen client relationships and support growth in higher-value, technology-enabled workforce solutions.
A Glance at AMN’s EstimatesThe Zacks Consensus Estimate for AMN’s earnings per share (EPS) implies year-over-year growth of 127.9% to $3.10 in 2026, followed by a 62.6% decline to $1.16 in 2027. In the past 60 days, the consensus mark for the company's 2026 EPS has improved 14.8%.
Revenues are projected to grow 20.9% to $3.30 billion in 2026 and decline 20.3% to $2.63 billion in 2027.
Image Source: Zacks Investment Research
AMN Stock: Risks & ChallengesChallenges remain for the company as it moves through the second half of 2026. AMN Healthcare remains dependent on sustained demand improvement in Nurse and Allied, while bill rates have yet to rise broadly and industry competition remains elevated. The Kaiser contract renewal process is expected to be competitive, with procurement generally seeking better terms. International nurse growth could moderate in 2027 if Embassy appointment delays persist, while Language Services continues to face pricing compression and softer demand tied to immigration policies. Execution on the locum tenens technology transformation, globalized language-services delivery and conversion of higher staffing orders into placements will be critical to restoring broader growth and improving profitability.
ConclusionThis Zacks Rank #3 (Hold) company’s 2026 rally appears supported by improving underlying demand rather than a single catalyst. Stronger nurse and allied volumes, better fulfillment, technology-enabled execution and persistent healthcare workforce shortages provide multiple avenues for growth. However, investors should watch the normalization of the second quarter’s one-time benefits, pricing pressure and the sustainability of the recent demand recovery. With AMN positioning itself for further organic growth and potential industry consolidation, the stock’s surge reflects growing optimism around a broader recovery in healthcare staffing.
Stocks to ConsiderSome better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , Veracyte (VCYT - Free Report) and West Pharmaceutical (WST - Free Report) .
Globus Medical, currently sporting a Zacks Rank #1 (Strong Buy), reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Veracyte, currently flaunting a Zacks Rank #1, reported a second-quarter 2026 adjusted EPS of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
West Pharmaceutical, carrying a Zacks Rank #2 (Buy) at present, reported second-quarter 2026 adjusted EPS of $2.37, which beat the Zacks Consensus Estimate by 13.9%. Revenues of $872.3 million surpassed the Zacks Consensus Estimate by 4.2%.
WST has an estimated long-term earnings growth rate of 16%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 17.4%.
Elastic dokončil akvizici společnosti Deductive AI. Cílem je posílit Elastic Observability o více automatizace s využitím AI pro rychlejší vyšetřování a řešení provozních incidentů.
Elastic (NYSE: ESTC) has completed the acquisition of Deductive AI, an AI-powered investigation platform that helps engineering teams identify and resolve production issues faster. The acquisition advances Elastic's goal to set the standard for production incident investigation by bringing more AI-powered investigation and automation to Elastic Observability.
As modern applications grow more distributed, interconnected and complex, engineers have more telemetry than ever, but spend too much time manually piecing together information across tools to understand what happened, why it happened, and what to do next. Deductive AI moves beyond simply summarizing alerts or suggesting where to look. Its technology is designed to take on more of the investigation itself while keeping engineers in control.
"Engineering teams today are drowning in telemetry but starved for answers," said Ash Kulkarni, chief executive officer, Elastic. "We have been building AI into Elastic Observability to move teams from detection to resolution faster. Deductive AI brings a sophisticated reinforcement learning harness for root cause analysis that accelerates this work. Together with the depth of telemetry and context in Elastic, it brings us closer to fundamentally changing how production incidents are investigated."
Deductive AI adds an AI SRE agent that gathers evidence, forms and tests hypotheses, and reasons across code, telemetry, and organizational knowledge to determine root cause. Its investigation engine learns which paths lead to useful evidence and successful outcomes, so every investigation can improve the next. Combined with Elastic’s ability to infer meaningful entities, relationships, and significant operational events from telemetry, these capabilities will help engineering teams investigate and resolve production issues faster.
"We've always believed that engineering teams deserve better than hours spent manually tracing the root cause of every incident," said Rakesh Kothari, former chief executive officer and cofounder, Deductive AI. "Joining Elastic lets us bring that conviction to a much larger audience and dramatically accelerate the development of AI-powered investigation capabilities. The opportunity ahead is unlike anything we could have built on our own."
Existing Deductive AI customers will continue to receive support while integration plans are developed. Additional product roadmap details will be shared in the coming months.
Read the blog to learn more.
About Elastic
Elastic (NYSE: ESTC) integrates its deep expertise in search technology with artificial intelligence to help everyone transform all of their data into answers, actions, and outcomes. The Elasticsearch Platform, which is the foundation for its search, observability, and security solutions, is used by thousands of companies, including more than 50% of the Fortune 500. Learn more at elastic.co.
Elastic and associated marks are trademarks or registered trademarks of elasticsearch B.V. and its subsidiaries. All other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260824863894/en/
Doximity rozšiřuje AI Search a klinickou AI, přičemž aktivních workflow preskriberů meziročně přibylo o více než 30 %. Vyšší náklady na AI ale tlačí marže dolů.
Key Takeaways Doximity's AI Search is opening a new commercial growth avenue across more than two dozen programs.Clinical AI adoption is rising, with active workflow prescribers up more than 30% year over year.Higher AI compute costs are pressuring margins as pharma advertising budgets remain tight. Doximity (DOCS - Free Report) is entering a pivotal phase as it accelerates investments in artificial intelligence to expand beyond its core physician engagement platform. While robust physician adoption, growing enterprise AI deployments and exceptional cash generation strengthen its long-term outlook, a sluggish pharma advertising market, rising AI investments and commercialization risks could temper near-term financial performance.
Shares of this Zacks Rank #3 (Hold) company have lost 42.8% year to date compared with the industry's 15.5% decline. The S&P 500 Index has risen 11.8% during this period.
Doximity, with a market capitalization of $4.51 billion, is a global specialty medical device company.
Image Source: Zacks Investment Research
DOCS’ bottom line is estimated to improve 1.7% over the next five years. Its earnings beat estimates in two of the trailing four quarters and missed twice, delivering an average surprise of 3.13%.
What's Driving DOCS’ Performance?AI Search Is Opening a New Commercial Growth Avenue: Doximity's AI Search business is emerging as a potentially significant incremental revenue stream, with the company already onboarding its first cohort across more than two dozen programs. Management said new AI Search contracts are driving the increase in fiscal 2027 revenue guidance, with most contracted revenues expected to be recognized in the third quarter.
The product is helping Doximity access higher-level decision-makers and innovation budgets at pharmaceutical companies, expanding its commercial relationships beyond traditional digital marketing. Management also noted that AI Search currently generates more than 10 times the revenue per search relative to its cost, indicating attractive unit economics that could improve further as utilization scales.
Rapid Clinical AI Adoption Strengthens Competitive Position: Doximity is gaining meaningful traction in clinical AI, with quarterly active workflow prescribers increasing more than 30% year over year and nearly half of them using AI tools. AI prompt volume rose more than 25% sequentially, while AI Scribe users increased sharply. The company's Ask platform also ranked strongly in the independent NOHARM study, posting a 4.8% clinical error rate compared with 13.6% for Anthropic's best-performing model cited by management. The combination of physician engagement, drug-reference integration and more than 12,000 physician PeerCheck editors could strengthen trust among hospitals and clinicians, providing an important competitive advantage as healthcare AI adoption accelerates.
Expanding Health-System Adoption Creates Opportunity: Doximity's enterprise AI footprint is expanding rapidly, with 165 signed health-system AI clients, including eight top Honor Roll hospitals. Recent wins with major academic institutions demonstrate that Doximity is increasingly becoming part of institutional clinical workflows rather than simply serving as a physician networking platform.
Management believes the market is moving toward greater emphasis on privacy, risk management and clinical accuracy, areas where Doximity believes its physician-reviewed AI architecture provides differentiation. The growing adoption of AI Search, Ask and Scribe also creates opportunities to cross-sell multiple products within the same health system, potentially increasing customer lifetime value and reducing dependence on pharmaceutical advertising over time.
What’s Weighing on DOCS StockAI Investment is Compressing Margins: Doximity's transition toward AI is creating a meaningful near-term profitability trade-off. Adjusted gross margin declined 300 basis points year over year to 88% in the first quarter, primarily because of higher AI compute costs required to support stronger-than-expected clinician usage.
Management expects elevated AI spending to continue throughout fiscal 2027, with adjusted EBITDA guidance implying a 47% margin, below the 48% achieved in the first quarter. Approximately 90% of incremental AI expenses will support the clinical AI suite and be recognized in cost of revenues. Although management expects eventual efficiency improvements, the timing mismatch between investment and monetization could constrain earnings growth in the near term.
Pharmaceutical Advertising Budgets Remain Tight: Despite improving customer engagement, Doximity continues to operate in a relatively cautious pharmaceutical spending environment. Although management characterized the overall buying environment as stabilizing but pressure still remains. Management maintains expectations for mid-single-digit growth in the HCP digital marketing market.
Doximity's full-year revenue guidance of $671-$681 million represents only 5% growth at the midpoint, suggesting that the underlying core business remains relatively subdued. Although AI Search is helping the company access innovation and analytics budgets, traditional pharmaceutical marketing remains sensitive to budget cycles and shorter-term commitments. Consequently, slower recovery in pharma spending could limit growth while the company simultaneously increases AI-related expenses.
Customer Concentration and Contract Structure Create Uncertainty: Doximity's strong relationships with large customers also create concentration risk. The company’s 127 pharma and hospital customers generating more than $500,000 annually accounted for 83% of total revenues, while its top 20 customers achieved 112% net revenue retention. Although these figures demonstrate strong customer economics, reliance on a relatively concentrated group of large accounts makes revenues sensitive to changes in pharmaceutical budgets and individual customer spending decisions.
Management also noted that AI Search initially launched with conservative inventory caps and shorter three- to four-month commitments, highlighting that the new revenue stream is yet to establish long-duration contract visibility. Larger, longer contracts during the upcoming upfront season will be key to improving predictability.
Estimate TrendThe Zacks Consensus Estimate for fiscal 2027 revenues is pegged at $675.7 million, implying growth of 4.8% from the year-ago reported figure. The consensus mark for adjusted EPS is pinned at $1.33, indicating a decline of 12.5% from the previous year’s recorded level.
In the past 30 days, DOCS’ earnings estimate for fiscal 2027 has declined 7 cents.
Stocks to ConsiderSome better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , Veracyte (VCYT - Free Report) and West Pharmaceutical (WST - Free Report) .
Globus Medical, currently sporting a Zacks Rank #1 (Strong Buy), reported a second-quarter 2026 adjusted earnings per share (EPS) of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Veracyte, currently flaunting a Zacks Rank #1, reported a second-quarter 2026 adjusted EPS of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
West Pharmaceutical, carrying a Zacks Rank #2 (Buy) at present, reported second-quarter 2026 adjusted EPS of $2.37, which beat the Zacks Consensus Estimate by 13.9%. Revenues of $872.3 million surpassed the Zacks Consensus Estimate by 4.2%.
WST has an estimated long-term earnings growth rate of 16%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 17.4%.
IonQ oznámila tržby za 2. čtvrtletí ve výši 80,1 milionu USD, meziročně o 287 % vyšší, a zvýšila výhled tržeb pro rok 2026 na 280–290 milionů USD. QUBT ve stejném období zvedla tržby na 5,6 milionu USD z 61 000 USD.
Key Takeaways IONQ posted $80.1M in Q2 revenues, up 287%, while QUBT rose to $5.6M from $61,000.QUBT's Fab 2, NeuraWave, Dirac-3 and $42.5M backlog broaden its commercial opportunity.Analyst targets imply 125.18% upside for QUBT versus 67.54% for IONQ, favoring QUBT. After a volatile stretch for quantum stocks, second-quarter 2026 results from IonQ (IONQ - Free Report) and Quantum Computing Inc. (QUBT - Free Report) or QCi, both offer long-term opportunity. IonQ clearly delivered the larger headline numbers. Revenues reached $80.1 million, up 287% year over year, while management raised 2026 revenue guidance to $280 million-$290 million.
Yet QUBT may have delivered the more intriguing strategic quarter. Revenues jumped to $5.6 million from just $61,000 a year earlier. QCi also added Fab 2 through NHanced, prepared NeuraWave for deployment and installed Dirac-3 at a global consulting firm. The company ended June with $1.3 billion in cash, equivalents and investments. Its backlog was $42.5 million.
Image Source: Zacks Investment Research
Over the past 30 days, IONQ shares have gained 24.9%, compared with 12.1% for QUBT. Investors are still giving greater weight to IONQ’s stronger revenue growth and near-term commercialization progress. However, QUBT’s latest quarter points to a broader strategy, spanning photonics, chip manufacturing and quantum computing. While these businesses are still at different stages of commercialization, they give QUBT multiple potential sources of future revenues.
Let's get into more detail.
QUBT: Investment CaseQUBT’s second-quarter revenues jumped to $5.6 million from $61,000 a year earlier and $3.7 million in the first quarter. Cash, cash equivalents and investments were $1.3 billion. The company also completed its NHanced Semiconductors acquisition, launching Fab 2 and expanding advanced packaging and U.S.-based semiconductor manufacturing. Commercial validation is emerging through the deployment of its Dirac-3 optimization machine, NeuraWave’s commercial readiness and a Planck Dynamics agreement that could support deployments of up to 100 systems with potential value exceeding $10 million, subject to milestones.
Headwinds for QUBTThe biggest concern is that QUBT remains at a very early revenue scale relative to its ambitious technology portfolio. Despite the revenue surge, second-quarter operating expenses more than doubled to $21.8 million, including $7.3 million of acquisition-related costs. The company also spent approximately $180 million on its three 2026 acquisitions, reducing cash and investments from roughly $1.5 billion at year-end 2025. With a $42.5 million backlog, investors still need evidence that acquisitions, manufacturing expansion and photonics products can translate into sustained, scalable revenues rather than primarily increasing costs and complexity.
IonQ: Investment CaseIonQ enters the second half of 2026 with a substantially larger and faster-growing commercial revenue base than QUBT. Second-quarter revenues surged 287% year over year to $80.1 million, while organic revenue growth reached 132%. Commercial customers accounted for about 60% of revenues, international revenue for about 50% and multi-product revenue for about 25%. RPO increased 297% year over year and IonQ raised 2026 revenue guidance to $280-$290 million, excluding SkyWater. Its acquisition of SkyWater also creates a vertically integrated U.S. quantum platform, while recent DARPA, NRO, Sandia and Canadian initiatives broaden its exposure to government, defense, networking and sensing markets.
Headwinds for IONQIonQ’s growth remains expensive. Second-quarter adjusted EBITDA loss was $120.3 million, while GAAP net loss reached $1.87 billion, largely driven by a noncash warrant mark-to-market impact. SkyWater-related spending also increased near-term costs. Excluding SkyWater spending, adjusted EBITDA loss would have been $95.6 million. More importantly, the $1.8-billion SkyWater acquisition raises execution and integration demands even as IonQ accelerates its hardware roadmap.
2026 Estimates: IONQ Vs. QUBTFor the full year, the Zacks Consensus Estimate for IONQ’s bottom line is pegged at a loss of $1.19 per share, implying a 34.6% improvement over the 2025 reported figure.
Image Source: Zacks Investment Research
In contrast, the Zacks Consensus Estimate for QUBT’S 2026 bottom line is pegged at a loss of 18 cents per share, implying a 63.6% widening over the 2025 reported loss.
Image Source: Zacks Investment Research
Technical Analysis: IONQ Vs. QUBTAs of Aug. 21, both stocks remained near their 50- and 200-day SMAs. IonQ traded slightly above its 50-day SMA and essentially at its 200-day SMA, signaling a relatively balanced trend after its recent recovery.
Image Source: Zacks Investment Research
QUBT, on Aug, 21, was also just above its 50-day SMA but remained below its 200-day SMA, indicating weaker longer-term momentum.
Image Source: Zacks Investment Research
Bullish Price Target for QUBT over IONQBased on short-term price targets offered by 12 analysts, the average price target for IonQ represents an increase of 67.54% from the last closing price of $41.53.
Image Source: Zacks Investment Research
Based on short-term price targets offered by six analysts, the average price target for QUBT represents an increase of 125.18% from the last closing price of $8.14.
Image Source: Zacks Investment Research
Final Take: IONQ or QUBT?Despite IONQ’s stronger revenue growth and commercialization progress, QUBT’s substantially higher 125.18% price-target upside makes it more attractive at present. This view also aligns with its Zacks Rank #3 (Hold), versus IONQ’s Zacks Rank #4 (Sell). Investors may consider booking profits in IONQ after its strong recent run, particularly given its elevated valuation, significant losses and integration risks following the SkyWater deal. Meanwhile, QUBT’s strategic expansion, strong liquidity and higher upside support a hold stance while investors await further execution. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Nový Zéland zvažuje zákaz sociálních sítí pro uživatele mladší 16 let a pokuty až do 10 % globálních tržeb pro platformy, které pravidla poruší. To zvyšuje regulační riziko pro Meta a Alphabet.
Platforms could face fines of up to 10% of global revenue.
Meta Platforms Inc. (META, Financials) and Alphabet Inc. may face another regulatory issue. The New Zealand Prime Minister Christopher Luxon claimed his party will introduce social media bans for under-16s.
The suggested fines make this crucial for investors. According to Reuters, noncompliant platforms might be fined 10% of global revenue.
The measure would compel corporations to reasonably verify users' ages using account information, face technology, and digital identity documents. That would highlight Instagram, Facebook, and YouTube.
Not only New Zealand would act. Australia banned under-16 social media, a model other countries could follow as kid safety and online addiction concerns grow.
One crucial note. The New Zealand idea is not yet legislation and may not pass. Luxon's coalition partner New Zealand First has opposed the bill. Travel direction matters.
If additional countries adopt age restrictions with substantial financial penalties, social media businesses may face increased compliance costs and fewer ways to entice younger members. Meta and Alphabet may face a wider regulatory risk from a local policy struggle.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Tesla klesla v pondělí ráno asi o 1,7 % poté, co ji čínské stažení z trhu donutilo řešit problém s nouzovým otevíráním dveří u zhruba 2,98 milionu vozů. Čína navíc od roku 2027 zakáže plně skryté vnější kliky dveří.
The record safety campaign targets nearly six times Tesla's latest quarterly deliveries. Summary
Tesla accounts for approximately 69% of all vehicles included in China’s recall.
Tesla (TSLA), the electric-vehicle, energy-storage and robotics giant, fell approximately 1.7% to $356.70 Monday morning as China's sweeping automotive recall rattled investors. Tesla must fix emergency door-release problems across roughly 2.98 million vehicles—more than any other automaker caught in the regulatory crackdown.
The full recall reaches approximately 4.3 million vehicles from nine manufacturers. The concern is simple but serious: electronic doors may become difficult to open after a crash or power failure. Tesla can tackle most of the problem through remote software updates and clearer emergency-release labels, keeping the immediate repair bill contained. The next hurdle is harder. China will ban fully concealed exterior door handles beginning in 2027, raising the prospect of physical redesigns across future models.
Tesla delivered more than 480,000 vehicles during the second quarter, meaning the recall covers more than six quarters of current global deliveries. The shares also sit 7.01% above their $333.34 GF Value™, leaving little room for another regulatory surprise. A software patch may solve today's problem, but at more than 300 times earnings, Tesla's premium valuation makes even a fixable safety issue hit harder.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Amazon vyvíjí novou vysoce automatizovanou doručovací stanici Project Tetromino, která má pomocí AI a robotiky zpracovávat balíky až 2,5krát rychleji než současný návrh.
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
An Amazon worker loads boxes into a delivery vehicle. Helen H. Richardson/MediaNews Group/The Denver Post via Getty Images Amazon is developing a new generation of highly automated warehouses that use AI and robotics to process packages at the final stop before delivery.
The initiative, internally called Project Tetromino, is intended to build "fully automated" delivery stations, according to an internal planning document from last month that Business Insider reviewed. Delivery stations are the final facility in the shipping process, receiving packaged items from fulfillment centers before sorting and staging them for drivers to deliver to customers.
According to the document, Amazon planned to invest $103 million in an initial Tetromino pilot in 2028, followed by five sites in 2029 and 10 more in 2030. Each 2029 site could cost about $85 million, bringing the total Tetromino investment to more than $530 million by 2029, the document said. It also said Tetromino could process packages at roughly 2.5 times the rate of its existing delivery station design.
An Amazon spokesperson told Business Insider that this is an "early-stage concept" and the specific financial figures and road map in the document are "inaccurate and don't reflect our current plans."
"We're always exploring and testing new technologies across our operations to improve safety and the delivery experience for customers," the spokesperson said. "Like any early-stage concept, this is one of many initiatives we regularly evaluate, and plans evolve significantly as we learn."
Tetromino offers a glimpse of how Amazon is trying to automate one of the most stubbornly manual parts of its logistics network. Industry analysts say tasks such as organizing and loading packages into vehicles at delivery stations remain difficult and expensive to automate.
The project comes as Amazon accelerates a broader warehouse automation push. On its latest earnings call in July, the company said it expects to more than double its fleet of robotic arms in 2026. Business Insider previously reported that Amazon is also deploying software that automatically recommends where warehouse workers should be assigned as workloads change.
Amazon's Tetris-like challengeOne of Tetromino's key technologies could come from Boxbot, an AI and robotics supply chain startup, according to the planning document. Boxbot's system moves packages from conveyors onto trays for storage, then uses AI to retrieve and sequence them for delivery. Boxbot's website says the system can make the vehicle-loading process up to 10 times faster. Boxbot did not immediately respond to a request for comment from Business Insider.
The Tetromino name itself may be a nod to the game Tetris, reflecting the puzzle-like challenge of efficiently organizing packages for delivery vehicles.
Amazon isn't alone in trying to automate these tasks. FedEx is expanding its use of AI-powered Dexterity robots that autonomously load packages into trailers, while UPS and DHL use robots for unloading. The Amazon spokesperson also pointed to delivery station pilots announced last year as part of a €700 million investment in European facilities, including machines that unload, sort, and scan packages.
The push toward more automated facilities raises questions about what Amazon's warehouses will ultimately need humans to do.
Amazon robotics chief Tye Brady previously told Business Insider that robots are intended to make frontline work safer and more efficient, not replace employees. Nevertheless, Amazon has internally projected that some warehouse robots will "flatten" its hiring curve over the next decade, Business Insider previously reported.
The Amazon spokesperson told Business Insider the company's delivery-station initiatives are "designed to complement and empower our workforce and employees remain central to how we operate."
Have a tip? Contact this reporter via email at [email protected] or Signal, Telegram, or WhatsApp at 650-942-3061. Use a personal email address, a nonwork WiFi network, and a nonwork device; here's our guide to sharing information securely.
Read next
Eugene Kim You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Eugene is Business Insider’s Chief Tech Correspondent, where he leads coverage of Amazon. His reporting spans the company’s retail operations, AWS, Alexa, and its secretive internal work culture.Previously, he worked at CNBC, Fortune Magazine Korea, and Japan's Yomiuri Shimbun. He holds degrees from NYU and Columbia University’s Graduate School of Journalism.In 2022, Eugene broke a story uncovering Amazon’s practice of deceptively enrolling customers in Prime and deliberately making cancellation difficult. A year later, the Federal Trade Commission sued the company, citing his reporting. That case culminated in a record $2.5 billion settlement in 2025.His reporting has earned multiple honors, including the SF Press Club’s Bay Area Journalism Award and SPJ NorCal’s Excellence in Journalism Award.Eugene lives in the Bay Area. Contact him via email at [email protected], or Signal, Telegram, or WhatsApp at 650-942-3061. Use a personal email address, a nonwork WiFi network, and a nonwork device; here's our guide to sharing information securely. ExpertiseAmazon, Jeff Bezos, Andy Jassy, e-commerce, and cloud computing.Popular ArticlesAmazon:Internal Amazon emails give an exclusive look at how CEO Andy Jassy has started to run the company, with obsessive attention to the retail business and what some employees feel is micromanagingAndy Jassy will be the next CEO of Amazon. Insiders dish on what it's like to work for Jeff Bezos' successor, who built AWS into a $40 billion business.Internal documents show Amazon has for years knowingly tricked people into signing up for Prime subscriptions. 'We have been deliberately confusing,' former employee says.Inside Amazon's flailing brick-and-mortar ambitions: missed projections, pressure to cut costs, and a war with Whole FoodsInside Amazon's complex employee-review system, where workers feel left in the dark and managers expect to give 5% of reports bad reviewsAfter 28 years, 'Day 2' finally arrives at AmazonAWS, Alexa, healthcare:Inside Amazon's struggle to break into the lucrative market for SaaS business applications, including an internal pitch to buy $38 billion HubSpotInside Amazon's struggle to crack Nvidia's AI-chip dominanceAmazon's AI data center dream runs into the reality of 'zombie' facilities, higher costs, and labor shortagesAmazon is gutting its voice assistant, Alexa. Employees describe a division in crisis and huge losses on 'a wasted opportunity.'Amazon is working on a new 'Remarkable Alexa,' but internal politics and technical issues plague the projectAmazon projected huge losses from its healthcare business in 2024, but strong sales growth, internal document reveals
Image Credits:Amazon Over the weekend, Amazon significantly raised the prices of its hardware devices, jacking them up by as much as 60 percent in some cases.
The price explosion impacted Fire TVs, Echos, Kindles, and Eeros. One egregious example that’s been cited is that of the Echo Dot, one of Amazon’s cheapest smart speakers, the price of which jumped 60% overnight, from $49.99 to $79.99. Price tracking sites like CamelCamelCamel show the stark uptick, which has previously hovered much lower.
When reached for comment by TechCrunch, Amazon shared the following: “The consumer electronics industry is facing significant increases in memory and storage component costs. After absorbing these increases for as long as we could, we recently adjusted pricing across our product lines.”
The company also said that it would continue to offer occasional promotions to customers over the course of the next year.
Amazon’s price hikes reinforce the reality that it’s a terrible time to buy hardware. The global memory shortage fueled by the AI boom (also known as “RAMmageddon“) is driving up the cost of producing devices of all stripes. As a result, companies are increasingly passing on the costs to their customers.
In a sign of the times, Apple recently hiked its prices, and has sought to offset the steep new rates by introducing a device leasing program, thus allowing users to pay off their devices over time.
The RAM shortage is expected to continue throughout 2027 before prices potentially crest and stabilize in 2028.
NIKE má v segmentu Running pět po sobě jdoucích čtvrtletí dvouciferného růstu a získala zhruba pět procentních bodů podílu na klíčových trzích. Lifestyle ale dál slábne, hlavně u modelů Air Force 1, Dunk a Air Jordan.
Key Takeaways NIKE's Running business has posted five straight quarters of double-digit growth.Refreshed Pegasus, Vomero and Structure franchises are driving performance-focused product momentum.Running gained five points of market share in key regions, while Lifestyle franchises are under pressure. NIKE, Inc.’s (NKE - Free Report) Running business has emerged as a key spot as its product-led turnaround gains momentum. The company is strengthening its Running portfolio by refreshing key franchises such as Pegasus, Vomero and Structure, with products designed to address specific runner needs, including cushioning, stability and energy return. The company is also broadening its lineup across various price points while accelerating the introduction of performance-focused products.
NIKE’s greater emphasis on performance-led innovation has accelerated Running growth, signaling strong consumer acceptance of its new product offerings. NKE has posted five consecutive quarters of double-digit Running growth, adding approximately $1 billion to the business in fiscal 2026. It has also captured around five percentage points of market share in statement Running footwear across North America and Western Europe, highlighting the growing impact of its renewed focus on performance-driven innovation and its ability to win back consumers.
The momentum is not limited to North America and Western Europe. Running also grew mid-single digits in Greater China in the fourth quarter, despite the broader market remaining under significant pressure. In China, NIKE said the Pegasus 42 launch performed well across roughly 2,000 elevated doors, while Running and Global Football were among the stronger areas of the business. In EMEA and APLA, Running also delivered double-digit growth, demonstrating that the category is gaining traction across multiple regions. The improvement is being driven by a sharper product strategy.
In short, NIKE’s Running business has emerged as a key spot in its turnaround, demonstrating that its renewed emphasis on sport, innovation and athlete-focused products is beginning to gain traction. The category’s strong performance provides early evidence that the company’s Sport Offense strategy is working, particularly when it combines consumer insights, differentiated product innovation and a sharper focus on performance needs.
However, the company’s Lifestyle business remains under pressure, particularly across established franchises such as Air Force 1, Dunk and Air Jordan. Sportswear and Jordan Streetwear continue to face challenges from weak sell-through and cautious consumer spending. While Running alone cannot fully offset the weakness in Lifestyle, its strong performance demonstrates that NIKE can reignite consumer demand through product innovation and performance-led offerings rather than relying primarily on established lifestyle franchises.
NKE’s Peerslululemon athletica inc. (LULU - Free Report) is putting greater emphasis on product newness, technical performance and innovation. LULU has been specifically increasing the frequency and breadth of new styles while maintaining its premium positioning. lululemon is leveraging its innovation platform and expanding beyond traditional yoga and core categories into areas such as running, training, tennis, golf, hiking and footwear.
adidas AG’s (ADDYY - Free Report) innovation strategy is centered on athlete-led product development, advanced technologies, local consumer insights and a combination of performance innovation with lifestyle appeal. adidas is pursuing a broad-based growth strategy centered on product innovation, performance and lifestyle relevance. ADDYY is strengthening key performance categories such as Running, Football and Training through new technologies and athlete-focused products, while simultaneously refreshing its Lifestyle portfolio.
NKE’S Price Performance, Valuation and EstimatesShares of NIKE have lost 34.5% in the past six months compared with the industry’s decline of 29.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, NKE trades at a forward price-to-earnings ratio of 21.69X compared with the industry’s average of 19X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for NKE’s fiscal 2027 and fiscal 2028 earnings implies year-over-year growth of 10.1% and 34.5%, respectively. The company’s EPS estimate for fiscal 2027 has been stable while that of fiscal 2028 has moved south in the past 30 days.
Curaleaf znovu odmítla nabídku Aurora Cannabis na převzetí a uvedla, že je připravena kdykoli jednat o dohodě v zájmu akcionářů. Tvrdí, že Aurora dlouhodobě ničí hodnotu pro akcionáře.
Aurora's selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value
Curaleaf reiterates its willingness to meet anytime to discuss a deal in the best interests of shareholders
, /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s (TSX: ACB) (NASDAQ: ACB) ("Aurora") latest public statements regarding Curaleaf's offer for Aurora:
"Aurora's hollow protests and completely misleading statistics change nothing about reality: if its multi-year turnaround strategy were delivering the value management claims, the company's valuation would reflect it. Aurora has repeatedly failed to demonstrate both a credible plan and the ability to execute, resulting in significant lost shareholder value.
It's time to focus on the facts.
Curaleaf is offering shareholders a substantial premium and the opportunity to participate in the upside of a larger, stronger global platform led by a management team with a proven track record of creating shareholder value. Curaleaf is ready to deliver value to Aurora shareholders, as it has for Curaleaf's shareholders.
The market has spoken. Aurora shareholders have waited long enough. They deserve results and they deserve value now."
Curaleaf Fully Rejects Aurora's Characterization of Discussions Between the Two Companies:
"Aurora's attempt to mischaracterize 'engagement' is disappointing and insulting to shareholders. We have not had a single conversation on the substance of a deal. Everyone involved in these types of discussions knows the difference. We have posted this correspondence in full on our website: grow.curaleaf.com.
Our bid is based on the latest numbers that were published on August 5, 2026, which is what we and the market are aware of. If Aurora has better information, we welcome the opportunity to review it. But they have refused to engage, refused to sign an NDA, refused a site visit despite posturing that they have been 'open.' That's not true constructive engagement.
We continue to remain willing to meet anytime to discuss a deal."
Aurora continues to cherry-pick statistics that present an incomplete picture of the business. Shareholders deserve to understand the full context:
Shareholder value under Aurora management has suffered: Aurora shareholders have endured the multi-year transformation that will not end but has cost more than C$400M in inventory impairments and "business transformation costs" under current leadership. Meanwhile, Aurora's shares declined approximately 35% over the past year through August 10, 2026, while Curaleaf's shares increased approximately 56%. Aurora's statements regarding 17% international growth are misleading: Aurora cites supposed international growth while ignoring recent declines in the size of that business, which generated approximately C$5 million less revenue in June than it did just three months earlier. Aurora reported June quarter adjusted EBITDA that was 63% lower than the March quarter, and that result included approximately C$5.1 million of business transformation cost add-backs. Excluding those add-backs, adjusted EBITDA would have been meaningfully negative, while cash flow from operations was negative C$4.4 million. Aurora's attempts to dismiss cultivation data taken directly from its own public disclosures. Our bid relies on cultivation metrics of 114 grams per plant that are taken straight from Aurora's latest audited fiscal 2026 financial statements. Curaleaf's cultivation yields are more than double the 114 grams per plant disclosed in Aurora's public filing. If there is better information available, shareholders deserve to see it. Aurora's own guidance points to a business that is expected to become smaller and less profitable in fiscal 2027. Aurora is guiding to revenue levels approaching fiscal 2025 levels, adjusted gross margins declining from approximately 64% to the mid-to-high 50% range, and lower Adjusted EBITDA. These are not the characteristics of a business delivering the value creation management claims. The Market Has Responded Favorably to Curaleaf's Offer
"Aurora's share price increased materially following the announcement of Curaleaf's offer and has traded near the implied value of Curaleaf's proposal. This demonstrates that investors recognize the value and strategic logic of the transaction.
Curaleaf has put forward a substantial premium and a credible strategic rationale. The market appears to understand the value proposition, even if Aurora's management continues to dismiss it. Curaleaf remains ready to engage constructively at any time."
Aurora shareholders are urged to read the offer documents carefully and in their entirety. They are also available on Curaleaf's website and on SEDAR+ (sedarplus.ca) and EDGAR (sec.gov), and Aurora shareholders are encouraged to visit https://grow.curaleaf.com/ for additional information regarding the offer, including the strategic rationale for the offer, expected benefits of the combination of the two companies, FAQs, and other relevant materials.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
This press release contains certain "forward-looking statements" within the meaning of such statements under applicable securities laws. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward looking statements in this news release include statements regarding the terms of the Offer, the expected benefits of the Offer to the combined company and the financial and strategic benefits of the Offer noted above, synergies and efficiencies that may be achieved upon a combination of the businesses of Aurora and Curaleaf; and expectations with respect to business and geographical diversification of the combined entity. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release, including assumptions based upon Aurora's publicly disclosed information, and that there will be no change in the business, prospects or capitalization of Aurora or Curaleaf. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. A more complete discussion of the risks and uncertainties facing the Company appears in the Company's Annual Information Form and continuous disclosure filings, which are available at www.sedarplus.ca.
Cautionary Statement Respecting Aurora Information
The information concerning Aurora contained in this press release has been taken from, or is based upon, publicly available information filed by Aurora with securities regulatory authorities in Canada prior to the date of this press release and other public sources. Aurora has not reviewed this press release and has not confirmed the accuracy and completeness of the Aurora information contained herein. Neither Curaleaf, nor any of its officers or directors, assumes any responsibility for the accuracy or completeness of such Aurora information. Curaleaf has no means of verifying the accuracy or completeness of any of the Aurora information contained in this press release.
Notice to U.S. Holders
The Offer is being made for the securities of a company formed outside of the United States. The Offer is subject to disclosure requirements of Canada that are different from those of the United States. Financial statements included in the documents, if any, will be prepared in accordance with Canadian accounting standards and may not be comparable to the financial statements of United States companies.
It may be difficult for a securityholder in the United States to enforce his/her/its rights and any claim a securityholder may have arising under the U.S. federal securities laws, since the issuer is located in Canada, and some or all of its officers or directors may be residents of Canada or another country outside of the United States. A securityholder may not be able to sue a Canadian company or its officers or directors in a court in Canada or elsewhere outside of the United States for violations of U.S. securities laws. It may be difficult to compel a Canadian company and its affiliates to subject themselves to a U.S. court's judgment.
Securityholders should be aware that the issuer may purchase securities otherwise than under the Offer, such as in open market or privately negotiated purchases.
Contacts
Media Contact
Kekst CNC
[email protected]
Investor Contact
Curaleaf Holdings, Inc.
[email protected]
Shareholder Contact
Carson Proxy Advisors
North American Toll Free Phone: 1-800-530-5189
Local (Collect outside North America): 416-751-2066
Email: [email protected]
Nvidia zveřejní výsledky hospodaření za 2. čtvrtletí 26. srpna a trh bude sledovat hlavně koncentraci tržeb u několika velkých zákazníků. Minule tři zákazníci tvořili 21 %, 17 % a 16 % tržeb.
Nvidia (NVDA -2.91%) is scheduled to report second-quarter earnings after market close on Aug. 26. As the biggest AI stock in the world, Nvidia's results will affect not only the company's share price but also valuations across the AI industry.
A new wrinkle will be revealed in Nvidia's upcoming earnings report. This revelation could have a sizable effect on Nvidia's stock price.
Today's Change
(
-2.91
%) $
-6.24
Current Price
$
208.48
This new detail could influence Nvidia's stock priceNvidia has become the largest AI company on the planet not by inventing AI technologies itself, but by selling its hardware to other AI businesses. The company's GPUs -- critical components that allow AI companies to train and execute their AI models -- are widely believed the be the best in the industry, with market share estimates typically at 85% or above.
Nvidia's future, therefore, relies on spending by the rest of the AI industry. But how much of this sales base consists of just a handful of hyperscalers?
Nvidia is already required to report material customers that account for more than 10% of total sales. But it isn't required to disclose the exact names of these customers. All we know is that last quarter, three customers accounted for 21%, 17%, and 16% of total revenue, respectively. It's not known, however, whether these customers are large AI companies or simply distribution intermediaries that, in turn, sell to a variety of AI customers.
Image source: Nvidia
Nvidia has warned investors of customer concentration in the past. "We have experienced periods where we receive a significant amount of our revenue from a limited number of customers, and this trend may continue," the company explained in the second quarter of last year, adding that "large cloud service providers" comprised around half of the company's data center revenue. Data center sales, meanwhile, accounted for 88% of Nvidia's overall revenue that quarter.
Analysts have long wanted more clarity into these numbers. Last quarter, Nvidia began breaking out "Hyperscaler" revenues versus "AI Clouds, Industrial & Enterprise" sales. This breakout essentially helps investors understand how much of Nvidia's sales are being driven by the AI market in general versus a handful of powerful customers, many of which are pursuing the development of their own GPUs.
Last quarter, data center revenue was remarkably balanced. Hyperscalers accounted for $37.9 billion in sales versus $37.4 billion in sales for other customers. That's pretty close to the breakdown the company alluded to this time last year.
Notably, however, hyperscaler revenues grew by just 12% versus 31% sequential growth for the rest of its customer base.
Investors should pay close attention to where these numbers head this quarter. If hyperscaler revenues spike, it could be a sign that Nvidia's chips remain in high demand among industry leaders. But it also increases Nvidia's reliance on a few customers. Last quarter, just three customers accounted for more than 50% of sales. But as mentioned, we cannot be sure if these customers are single entities or businesses that then sell to customers of their own.
Rising sales growth outside of the hyperscalers segment could also spell good or bad news. On one hand, it would lessen Nvidia's customer concentration. On the other hand, it could signal weakening demand among hyperscalers, which are desperate to reduce their own reliance on Nvidia.
What these numbers reveal, and how the market decides to interpret the data, should have an impact on Nvidia's share price after earnings are announced.
Analytik Cantor Fitzgerald tvrdí, že Nvidia může těžit z financování AI infrastruktury a partnerských vazeb, které posilují její pozici v ekosystému. Cenový cíl má na 350 USD, asi 67 % nad současnou úrovní.
Nvidia shares are under pressure ahead of the company's fiscal second-quarter 2027 results on Wednesday, but one analyst argues investors may be viewing the artificial intelligence leader through the wrong lens.
The stock fell about 2.5% Monday and was on track for its seventh consecutive losing session, potentially its longest losing streak since September 2022, according to Dow Jones Market Data.
Despite the recent weakness, Nvidia has gained about 12% this year.
That performance looks modest compared with the 59% advance in the PHLX Semiconductor Index over the same period.
Cantor Fitzgerald analyst CJ Muse believes the disconnect creates an opportunity.
"It is time to close your eyes" and bet big on Nvidia's stock, Muse wrote in a Monday note to clients.
He said once momentum returns, the stock is expected to move rapidly.
"When this stock starts moving, we think it is going to move very, very fast," he said.
Muse's bullish case rests partly on Nvidia's potential earnings growth.
He pointed to estimates of $17 in earnings per share for calendar 2027 and $25 for calendar 2028.
Based on those projections, Nvidia is trading at roughly 14 times the 2027 estimate and 10 times the 2028 figure.
Muse has a $350 price target on Nvidia, about 67% above current levels.
The analyst believes investors are currently "underweight" Nvidia, suggesting the stock is less represented in portfolios than its broader market position might warrant.
The argument is not simply that Nvidia will continue selling more GPUs.
Instead, Muse believes the company is becoming increasingly embedded in the financing and infrastructure that supports the AI ecosystem.
Nvidia's growing use of what Muse describes as "financial engineering" has attracted criticism, particularly because the company has taken equity stakes in AI companies including OpenAI and Anthropic and entered revenue-sharing arrangements with neocloud providers such as CoreWeave and Nebius.
Muse, however, sees those arrangements as increasingly important to Nvidia's competitive position.
"This strategy is becoming increasingly critical and one that we believe will shine as we move further through today's robust AI infrastructure buildout," he said.
The logic is that Nvidia is not simply supplying chips to customers.
By helping finance AI infrastructure, providing computing capacity and participating financially in the companies building that infrastructure, it can create deeper relationships that are harder for competitors to disrupt.
Muse argues that Nvidia's equity investments, revenue-sharing agreements and plans to help raise as much as $500 billion for AI infrastructure are effectively turning its GPUs "into a financeable, increasingly fungible asset class."
That could make it harder for customers to replace Nvidia hardware with competing chips.
Cantor Fitzgerald identified five potential catalysts that could change the market's perception of Nvidia.
One is greater clarity around data-center revenue in 2027.
Other companies have begun providing specific targets for their future infrastructure spending, while Nvidia has yet to offer comparable visibility.
Another potential catalyst is additional information from Anthropic ahead of its expected fourth-quarter 2026 IPO.
Investors have recently focused on concerns surrounding the AI company's July annual recurring revenue.
The firm also sees greater visibility into hyperscaler capital expenditure plans for 2027 and 2028 as potentially supportive for Nvidia.
Sustained growth among neocloud providers is another factor, particularly if Nvidia continues using financing and revenue-sharing arrangements to support data-center expansion.
Finally, Muse believes GPUs could increasingly become standardized as a new asset class through financing agreements, potentially broadening Nvidia's role beyond traditional semiconductor sales.
Custom chips remain a risk, but Nvidia is broadening its moatThe biggest challenge to Nvidia's dominance is increasingly coming from the company's largest customers.
Major cloud companies are developing custom AI accelerators to reduce their dependence on Nvidia, raising concerns that the chipmaker's market share could eventually decline.
Muse believes its neocloud strategy offers some protection against that risk.
Revenue-sharing agreements with neocloud companies could prove "much more resilient" because Nvidia is helping enable data-center deployments beyond the largest hyperscalers.
The company is also expanding its customer base among enterprises and sovereign AI programs while moving toward selling complete AI systems that include racks, networking and other components.
That broader strategy could make Nvidia less vulnerable to losing a particular chip program to a competitor.
Wall Street remains bullish ahead of resultsOther analysts are also maintaining positive views ahead of Nvidia's earnings.
Rosenblatt Securities has retained a Buy rating and expects Nvidia's revenue and earnings to exceed consensus estimates.
Benchmark has likewise reiterated its Buy rating and set a $335 price target.
The firm expects Nvidia to report revenue of about $92 billion and earnings per share of $2.10.
The earnings report will therefore provide an important test of whether Nvidia's fundamental growth can overcome concerns about valuation, custom-chip competition and the sustainability of AI infrastructure spending.
For Muse, however, the bigger opportunity lies in recognizing that Nvidia's competitive advantage may no longer be limited to its semiconductor technology.
Its financing relationships, software ecosystem, infrastructure partnerships and stakes in AI companies could create a network around Nvidia that is increasingly difficult to displace.
That strategy remains controversial. But if AI infrastructure spending continues accelerating, the same financial moves that investors have questioned could ultimately help Nvidia retain its position at the center of the AI boom.
Nvidia má ve středu znovu překonat vlastní prognózu, ale klíčovým tématem je podle analytiků omezená nabídka, ne poptávka. Wedbush uvádí, že firma skončila se závazky z dodávek ve výši 95,2 miliardy USD a celkovou nabídkou 145 miliard USD.
Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) is expected to top its own guidance again on Wednesday even as supply constraints, not demand, increasingly define the story.
The first order of business is the number itself, and most signs point to another beat. Nvidia guided for second-quarter revenue of $91 billion, plus or minus 2%, with gross margins of about 75%, implying earnings per share of roughly $2.03. Consensus sits at $92 billion and $2.09.
Over the last three quarters, Nvidia has handily exceeded its own guidance. Most analysts expect a similar beat this time, with management likely to meet or top the consensus October guide of $103.9 billion.
Wedbush, which reiterated an Outperform rating and $330 price target, argues component and material access, not end demand, now limits shipments. The firm called Nvidia's supply position the best in the industry: the company exited its first fiscal quarter with supply chain commitments of $119 billion, up from $95.2 billion, and total supply of $145 billion.
Vera Rubin entered full production following GTC Taipei, with the revenue ramp starting in the third fiscal quarter, and management has signaled the platform will likely stay supply constrained for its entire life. Memory pricing, a risk flagged into the last print, looks less worrying now too.
Wedbush cited feedback that Nvidia negotiated favorable HBM pricing for 2027, and that the 17% price increases reported for 2027 deliveries should let the company hold absolute, if not percentage, margins.
UBS backs the supply story with its own numbers, pointing to rising TSMC and industry-wide CoWoS packaging capacity and ample HBM supply. The firm raised its GPU unit estimates to about 8.8 million chips in calendar 2026 and 10.8 million in calendar 2027, lifting revenue estimates to roughly $418 billion and $681 billion for those years.
The group models gross margin in the mid-70% range through 2027, free cash flow of $211 billion and $360 billion over the period, and reiterated a Buy rating with a $280 price target based on 14 times its 2028 EPS estimate of about $20.
Demand isn't the worry either. All four of the largest US hyperscalers raised their 2026 capital spending plans again on their June-quarter calls, putting the group's combined spending at roughly $725 billion for the year, up from about $410 billion in 2025, per Wedbush. Neocloud, model builder and sovereign programs are growing even faster than hyperscale spending, and smaller neoclouds are reporting payback periods of just two to three years on AI hardware builds.
Nvidia's push to secure every input, chip supply, land, power, for customers like frontier labs and neoclouds is reshaping how analysts think about the company. Bank of America pointed to Nvidia's recently announced $105 billion in OpenAI-related commitments and said it expects more disclosure around off-balance-sheet commitments on the earnings call. The firm sees the strategy as securing demand durability but warns it also raises risk: a slowdown in AI demand could pressure both growth and the balance sheet.
XTB research director Kathleen Brooks went further, describing Nvidia as functioning almost like "a central bank to the tech industry," a reference to its role organizing a $500 billion third-party compute financing platform with KKR, BlackRock and other institutions.
The valuation gap
Bank of America argues the market is underpricing Nvidia for the risk it's actually taking. Using a sum-of-parts approach that applies peer multiples to the roughly 50% of free cash flow returned to shareholders and a discount to the remainder, the firm estimates Nvidia should trade at a blended 36 times and 22.5 times calendar 2027 and 2028 EV/FCF compared to 18 times and 15 times, a 50% and 34% discount.
Bank of America suggests boosting the share of free cash flow devoted to buybacks, currently below peers like AMD and Marvell at 75-100%, could help close that gap.
Shares of Nvidia are down 2.5% on Monday but have gained over 12% year to date.
The streamer is discussing bringing rival services onto its platform.
08/24/2026 12:28
Summary
Netflix has reportedly held talks about offering Peacock and Fox One.
Netflix Inc. (NFLX, Financials) may reconsider a streaming strategy rule. According to The New York Times, the business has considered adding Comcast's Peacock and Fox One to its platform. Netflix may integrate competing content or offer memberships, but no deal is imminent.
Nonetheless, the talks are notable. Netflix rarely sells competitive streaming services. In contrast, Amazon, Roku, and YouTube sell third-party subscriptions to become users' major gateways. That model is growing.
Antenna believes that one-third of new streaming subscriptions have come from third-party services, up 60% over the past three years. Netflix has tried several things. It added live and on-demand TF1 programming in June.
The appeal is straightforward. Netflix could increase engagement and solidify its position as the default streaming destination if it allowed consumers to manage other subscriptions and watch its own series.
Partners may share revenue and lose client control. Netflix must decide if being the biggest streaming service is enough or if it wants to be the streaming front door.
Disclosures
I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Walmart spouští novou dámskou módní značku Scenario s položkami kolem 25 USD, aby přilákal mladší zákaznice a zlepšil marže. Tahle sázka přichází poté, co srovnatelné tržby v USA bez paliv vzrostly v aktuálním čtvrtletí jen o 2,6 %.
Walmart Inc. (WMT, Financials) is trying again to be more than a location for people to buy food and basic apparel. The retailer is launching a new women's fashion brand called Scenario with hundreds of items including blouses, denim shirts, bags and accessories, many priced at around $25.
The objective is youthful buyers who desire greater flair without sacrificing the Walmart price. And that's important because clothes can do something food typically can't: carry better margins.
Walmart US comparable sales excluding fuel climbed 2.6% in its current quarter, compared with 4.1% in the prior period and below market estimates. This puts extra pressure on the corporation to find growth in sectors other than food and household needs. Fashion is one of those chances.
Walmart has worked for years to make its shops and website more competitive with Amazon.com Inc. (AMZN, Financials) and conventional clothes retailers, but the efforts have been hit and miss. Scenario provides a further opportunity. The brand targets women aged 35 looking for more attractive options than Walmart's existing essentials.
The goal is simple: get buyers in with low pricing, then show that Walmart can also compete on style. If Scenario catches on, Walmart might get a lot more than garment sales. It may refine its product mix and give customers another reason to spend beyond the supermarket aisle.
Johnson & Johnson v pondělí odpoledne vzrostl asi o 1,2 % na 273,31 USD, protože investoři vyhledávali defenzivní tituly. Tržby ve 2. čtvrtletí stouply o 6,6 % na 25,3 mld. USD a upravený zisk na akcii činil 2,90 USD.
, the pharmaceutical and medical-technology powerhouse, gained approximately 1.2% to $273.31 Monday afternoon. Technology stocks were cracking. Johnson & Johnson was climbing. Investors wanted defensive earnings—and they were willing to pay up for them.
The fundamentals gave buyers a reason. Second-quarter sales jumped 6.6% to $25.3 billion, while adjusted earnings hit $2.90 per share. Innovative Medicine delivered 6.8% operational growth. MedTech added 3.6%. Management lifted its operating outlook, although acquisition-related dilution later pressured reported profit guidance.
Here is the catch: safety looks expensive. At $273.31, the stock sits 41.91% above its GF Value estimate of $192.59 and trades at roughly 32 times earnings. Stelara is battling biosimilars. MedTech execution remains uneven. Recent deals will weigh on near-term profits. Johnson & Johnson offers stability, but the market is already charging a premium for it. The pipeline now needs to deliver.
Exxon Mobil klesl asi o 1,3 % poté, co ropa spadla o více než 2 %. Pokles přišel po dvou týdnech růstu cen ropy kvůli napětí kolem íránských exportů a přepravy v Perském zálivu.
, the integrated oil-and-gas titan, dropped approximately 1.3% to $162.97 Monday afternoon as crude sank more than 2%. Oil had rallied for two straight weeks as pressure on Iranian exports and restricted Gulf shipping tightened the supply outlook. Then the trade snapped back. The geopolitical premium was real—but never permanent.
Exxon's operating engine remains brutally strong. The company delivered second-quarter operating cash flow of $23.6 billion and free cash flow of $17.2 billion, powered by record Permian production and a massive refining network. That scale gives Exxon several ways to win. It does not need every barrel of oil to carry a crisis premium.
The valuation is where investors should stay sharp. Exxon's $162.97 share price sits 29.24% above its $126.10 GF Value estimate, signaling that plenty of strength may already be priced in. Sanctions could squeeze supply and reignite crude overnight. Weaker demand or diplomatic progress could unwind the premium just as quickly. Exxon can absorb an oil selloff better than most—but its stock will still feel the hit.
Phillips 66 za čtvrtletí oznámila upravený zisk 9,41 USD na akcii a výnosy 52,04 miliardy USD, obojí nad odhady. Rafinérská marže vyskočila na 24,08 USD za barel při využití kapacity 96 %.
Key Takeaways PSX shares jumped 17.5% in four weeks as second-quarter earnings and revenues beat estimates.Phillips 66's refining margin rose to $24.08 a barrel as utilization hit 96%, lifting pre-tax income.PSX faces a premium valuation and lower 2027 earnings estimate, pointing to expected normalization. Phillips 66 (PSX - Free Report) shares have gained 17.5% in the past four weeks, extending a rally backed by a sharp improvement in second-quarter results. Refining economics and midstream growth have strengthened the operating picture.
The question is whether those gains leave enough room for further upside. Earnings momentum remains favorable, but valuation, cyclical exposure and a lower 2027 earnings estimate argue for a more measured view.
PSX Rally Follows a Stronger Earnings BackdropSecond-quarter 2026 adjusted earnings were $9.41 per share, up from $2.38 a year earlier. The figure topped the Zacks Consensus Estimate of $7.68 by 22.5%.
Total revenues and other income rose to $52.04 billion from $33.52 billion and beat the consensus mark by 43.9%. That combination gives investors a materially stronger earnings base than a year ago.
Phillips 66 Refining Margins Add Earnings LeverageWorldwide realized refining margins climbed to $24.08 per barrel from $11.25 a year earlier, while crude capacity utilization reached 96%. Refining adjusted pre-tax income increased to $3.09 billion from $392 million.
Management expects lower net refinery additions and demand growth to support a tighter supply-demand balance, potentially sustaining stronger margins into 2027. Marathon Petroleum Corp. (MPC - Free Report) reported a second-quarter refining and marketing margin of $36.33 per barrel, driven primarily by higher crack spreads. Valero Energy Corporation (VLO - Free Report) reported $4.5 billion of refining operating income, versus $1.3 billion a year earlier.
PSX Midstream Growth Supports Cash Flow ResilienceMidstream adjusted EBITDA reached $1.05 billion as natural gas liquids pipeline throughput averaged 943,000 barrels per day and fractionation volumes hit 1.02 million barrels per day. Those results broaden the cash-flow base beyond refining.
Phillips 66 is also advancing Western Gateway, in which it holds a 49.9% interest, along with the 300-million-cubic-feet-per-day Zeus Gas Plant and 100,000-barrel-per-day Coastal Bend fractionator. These projects add future growth avenues across its midstream network.
Image Source: Phillips 66
Phillips 66 Valuation Leaves Less Room for ErrorPSX has a forward 12-month price-to-earnings ratio of 10.84 versus 9.57 for the Zacks sub-industry and a five-year median of 10.93. The recent share-price advance therefore leaves less valuation cushion if operating conditions soften.
The Zacks Consensus Estimate calls for 2026 earnings of $23.86 per share and 2027 earnings of $21.42. That decline points to normalization after the sharp 2026 earnings rebound.
Image Source: Zacks Investment Research
PSX Risks Could Interrupt the MomentumRefining and chemical earnings remain cyclical. Phillips 66 also recorded $839 million of mark-to-market pre-tax losses on short derivative positions in the first quarter, followed by about $450 million of favorable impacts across Refining, Marketing and Specialties and Renewable Fuels in the second quarter.
Renewable Fuels faces policy uncertainty because renewable identification number credit generation from foreign feedstocks could be cut in half after 2027. Total debt fell to $20.6 billion in the second quarter, but it remains above management's $17 billion target.
PSX Signals Favor Quality but Support a HoldThe operating setup remains constructive, but the recent rally, premium valuation and expected earnings normalization limit the margin for disappointment. The risk-reward balance now looks more even than the recent price momentum alone suggests.
PSX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.
It also has a VGM Score of A, Growth Score of A, Momentum Score of A and Value Score of B. Those favorable Style Scores highlight strength across growth, momentum and value characteristics, but they are designed to complement rather than override the Zacks Rank, supporting a measured near-term stance.
Pinterest ve 2. čtvrtletí zvýšil tržby o 18 % na 1,18 miliardy USD a upravený EBITDA vzrostl o 24 % na 311 milionů USD. Počet měsíčních aktivních uživatelů dosáhl rekordních 640 milionů.
Key Takeaways Pinterest posted Q2 revenue growth, record users and stronger EBITDA as its rebound gained traction.PINS' Performance AI tools improved ad optimization, with advertisers seeing better return on ad spend.Pinterest reached 640 million monthly active users, while higher AI and product costs tempered upside. Pinterest, Inc. (PINS - Free Report) shares have gained 21.7% in the past three months, putting the durability of the rebound at the center of the investment case. The advance comes as second-quarter revenue growth, record users and AI-led ad improvements show better operating traction.
Still, the rally has a mixed backdrop. Earnings estimates have moved lower and AI infrastructure and go-to-market spending are rising. Investors are weighing improving monetization against the risk that near-term earnings momentum may not keep pace with the stock's recovery.
Image Source: Zacks Investment Research
Pinterest's Q2 Strength Supports the ReboundSecond-quarter 2026 revenues increased 18% year over year to $1.18 billion. Non-GAAP earnings of 43 cents per share topped the Zacks Consensus Estimate of 36 cents by 19.4%, while U.S. and Canada revenues rose 18% to $880 million.
Profitability improved alongside the top line. Adjusted EBITDA increased 24% to $311 million, with the margin reaching 26%. Pinterest also generated $270 million in free cash flow, supporting the rebound with stronger earnings and cash generation.
PINS AI Ad Tools Strengthen MonetizationPinterest Performance+ automates campaign setup, bidding, budgeting, targeting and creative optimization. Advertisers using it have generated better return on ad spend and faster spending growth than non-adopters. Smart Assembly delivered a 6% average improvement in click-through rate in early alpha testing, while Business Assistant remains in beta.
Competition is moving quickly. Meta Platforms, Inc. (META - Free Report) reported second-quarter ad impressions up 14% and average price per ad up 12% while saying AI is accelerating its core business. Snap Inc. (SNAP - Free Report) posted 19% second-quarter revenue growth and cited improving advertising performance. Pinterest still must convert its AI tools into durable advertiser returns as rivals improve their ad platforms.
Pinterest Keeps User Growth at Record LevelsGlobal monthly active users reached 640 million in the second quarter, up 11% year over year. That marked Pinterest's 12th consecutive quarter of record users and its 11th straight quarter of double-digit user growth, with gains across all three reported regions.
Gen Z remains Pinterest's largest and fastest-growing cohort and represents more than half of its user base. The platform handles more than 80 billion searches each month, with the vast majority visual and more than half commercial, providing a sizable base for personalized discovery and shopping.
PINS Estimate Cuts and Costs Limit the Upside CaseThe current fiscal-year earnings per share estimate has moved 5.2% lower over the past four weeks and 10.7% lower over the past 12 weeks. Those revisions temper the earnings backdrop after the recent share-price gain and leave the rebound without an equally favorable estimate-revision signal.
Investment intensity is another offset. Non-GAAP cost of revenue rose 25% to $245 million in the second quarter, partly because of additional graphics processing unit capacity and tvScientific. Non-GAAP operating expenses increased 13% to $629 million, driven by sales and marketing plus research and development spending for AI and product initiatives.
Pinterest Signals Favor Growth Over MomentumThe rebound has operating support, but the evidence does not make a clean case for chasing PINS after a 21.7% three-month move. Revenue growth, record users and improving ad tools strengthen the fundamental case, while estimate cuts and higher investment spending keep the near-term setup balanced. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
PINS currently carries a Zacks Rank #3 (Hold). It has a VGM Score of B and Growth Score of B, compared with a Value Score of C and Momentum Score of D. Because the Zacks Style Scores complement rather than override the Zacks Rank, the combination points to favorable growth characteristics but a weaker momentum profile and a mixed short-term signal.
Pinterest těží z dvouciferného růstu tržeb a nástrojů AI, ale investoři sledují vyšší náklady a nerovnoměrnou monetizaci v zahraničí. Adjusted EBITDA ve 2. čtvrtletí vzrostla o 24 % při růstu tržeb o 18 %.
Key Takeaways Pinterest combines double-digit growth, valuation discount and AI tools as investors weigh its upside.PINS expects sales and EPS growth as AI investments support personalization and advertiser performance.Pinterest sees EBITDA gains, but higher costs and uneven international monetization remain key factors. Pinterest, Inc. (PINS - Free Report) combines double-digit revenue growth, solid projected earnings gains and a valuation below several benchmarks. Artificial intelligence (AI) is improving personalization and advertiser tools, adding to the growth case.
The key question is whether that monetization progress can outrun higher infrastructure costs, uneven international execution and weaker estimate revisions. The setup offers upside, but the risk-reward is not one-sided.
Pinterest's Valuation Discount Creates RoomPINS trades at 2.47X forward 12-month sales, below the Zacks sub-industry's 3.93X, the Zacks Computer and Technology sector's 6.36X and the S&P 500's 4.93X.
The discount is also sizable versus Pinterest's five-year median of 5.22X. That leaves room for multiple expansion if execution holds, but valuation alone does not establish that the shares are mispriced.
Image Source: Zacks Investment Research
PINS Growth Outlook Still Supports the Bull CaseProjected 2026 sales growth is 15.3%, while projected earnings-per-share growth is 27.5%. Revenues are expected to rise from $4.22 billion in 2025 to $4.87 billion in 2026 and $5.45 billion in 2027.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is $2.04 per share. The multiyear revenue and earnings trajectory supports the bull case, provided advertiser demand and execution remain on track.
Pinterest AI Spending Tests Operating LeveragePinterest's AI tools are designed to improve personalization and advertiser performance, but the investment burden is visible. Second-quarter non-GAAP cost of revenue rose 25% to $245 million, reflecting added graphics processing unit capacity and the full-quarter impact of tvScientific. Non-GAAP operating expenses increased 13%, driven by higher sales and marketing spending and research and development outlays for AI initiatives.
Adjusted EBITDA still grew 24%, faster than the 18% revenue gain, and its margin reached 26%. Management raised its 2026 adjusted EBITDA margin outlook to about 30%, showing that investment and margin expansion are progressing together for now.
Competitive pressure raises the bar. Meta Platforms, Inc. (META - Free Report) said AI is accelerating its core business, underscoring the pressure on Pinterest as larger ad platforms deploy similar technology. Snap Inc. (SNAP - Free Report) has launched AI Sponsored Snaps for interactive brand conversations, showing that AI-powered advertising is becoming a broader competitive focus.
PINS International Monetization is Still UnevenEurope revenues rose 12% in the second quarter, while Rest of World revenue climbed 38%. Monetization remains far behind the United States and Canada, where average revenue per user was $8.30 compared with $1.35 in Europe and $0.23 in Rest of World.
Pinterest is extending its United States and Canada go-to-market approach internationally, supported by new leadership and broader demand initiatives. Management has described the transition as a multiquarter journey, leaving execution as an important variable.
PINS Signals Point to Patience, Not AggressionFor now, PINS looks more like a hold-or-wait setup than an aggressive buy. The valuation discount, projected growth and improving adjusted EBITDA margins are positives, but the 2026 earnings estimate has declined 5.2% in the past four weeks, tempering the case for urgency.
The stock currently carries a Zacks Rank #3 (Hold). Its Growth Score of B and VGM Score of B indicate relatively favorable growth and combined style characteristics, while its Value Score of C and Momentum Score of D are less supportive. The Zacks Style Scores complement the Zacks Rank rather than override it, making continued execution and estimate trends important to watch. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Pinterest uzavřel s AWS smlouvu za 4 mld. USD do roku 2031 na podporu AI, vyhledávání a nakupování. Zároveň roste jeho nákladová základna kvůli kapacitě GPU a investicím do produktů.
Key Takeaways Pinterest committed $4B to AWS through 2031 to support AI, search and shopping experiences.PINS is scaling AI ads and search tools using data from billions of user interactions and searches.Pinterest faces higher AI costs as GPU capacity and product investments expand. Pinterest, Inc. (PINS - Free Report) has committed $4 billion to Amazon Web Services through 2031, adding a multiyear infrastructure obligation to its AI strategy. The investor question is whether deeper cloud investment can translate into enough product and monetization gains to justify a rising technology cost base.
The timing matters because Pinterest is already scaling AI across user experiences and advertising while spending more on GPU capacity. The deal increases the importance of converting those investments into durable revenue growth and profitability.
Pinterest Makes a Multiyear Bet on AWSPinterest expanded its AWS partnership on June 4, committing $4 billion in cloud services through 2031. The agreement is intended to support AI development, improve search and shopping experiences and modernize Pinterest's global visual-discovery infrastructure.
The 2031 horizon makes this a long-duration resource commitment rather than a short-term capacity purchase. Amazon.com, Inc. (AMZN - Free Report) is the other side of the infrastructure equation. AWS provides GPU-based compute, networking and storage for AI training and inference.
PINS Could Scale AI Search and Shopping FasterPinterest already has large-scale data and engagement to feed those systems. The platform processes more than 80 billion searches each month, with the vast majority visual and more than half commercial. Its Taste Graph also draws on more than 16 billion boards, providing curation signals for recommendations.
Pinterest Assistant is now available to the vast majority of U.S. users. Management says its open-source model approach can deliver cost per transaction at less than 8% of comparable closed proprietary models, giving Pinterest room to deploy more AI capabilities at a lower model cost.
Pinterest Ads Also Depend on AI InvestmentAd monetization is another target for AI investment. Performance+ automates campaign setup, bidding, budgeting, targeting and creative optimization, while advertisers using it have posted better return on ad spend and faster spending growth than non-adopters.
Smart Assembly produced a 6% average lift in click-through rate in early alpha testing, and Business Assistant remains in beta. Meta Platforms, Inc. (META - Free Report) adds competitive context. Meta said AI is accelerating its core business, while second-quarter ad impressions rose 14% and average price per ad increased 12%.
PINS Faces a Higher Cost Base as AI ScalesCosts are already moving higher. Second-quarter non-GAAP cost of revenue rose 25% to $245 million, driven by the full-quarter impact of tvScientific and added GPU capacity. Non-GAAP operating expenses increased 13% to $629 million, including research and development spending for AI and product initiatives.
Pinterest expects third-quarter non-GAAP cost of revenue to be roughly flat sequentially because of accelerated contractual benefits from a recently executed multiyear infrastructure agreement. Still, management expects modest second-half pressure on cost of revenue as a percentage of revenue from additional GPU capacity and tvScientific.
Image Source: Zacks Investment Research
Pinterest's Mixed Scores Fit the AWS Trade-OffThe AWS commitment expands Pinterest's AI capacity, but it also raises the execution burden. Search scale, AI shopping tools and ad automation create paths to monetize the added capacity, while the expanding cost base makes sustained revenue and adjusted EBITDA growth important to the investment case.
PINS currently carries a Zacks Rank #3 (Hold). It has a Growth Score of B and VGM Score of B, versus a Value Score of C and Momentum Score of D. The B grades indicate comparatively favorable growth and blended style characteristics, while the weaker Momentum Score points to less favorable near-term timing. Because the Style Scores complement the Zacks Rank rather than replace it, the mix supports a balanced short-term view. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Micron Technology's (MU -5.99%) CEO, Sanjay Mehrotra, sat down with CNBC's Jim Cramer last week at a construction site in Boise, Idaho, where the memory specialist is building two chip fabrication plants.
He had a lot to talk about: Micron's fiscal third-quarter revenue more than quadrupled year over year to $41.5 billion, and net income hit $28.2 billion, compared with $1.9 billion a year earlier. Guidance points to about $50 billion this quarter.
But the number I keep coming back to wasn't in any earnings release. It's the money customers are putting up upfront -- $22 billion in deposits and related commitments under the first 16 agreements.
"All our customers across our end markets will buy everything that we make," Mehrotra said. And data center customers, he added, want about 50% more supply than Micron can commit to delivering.
The driver, of course, is artificial intelligence (AI). Data centers built for it need enormous amounts of memory, and the industry can't manufacture enough.
But what do the contracts require both sides to do -- and what happens if prices fall?
Image source: Micron.
Binding, both waysAlong with its fiscal third-quarter report in late June (the period ended May 28), Micron said it had signed 16 strategic agreements with data center, consumer, and automotive customers. And Mehrotra told Cramer the company has signed more since then.
They are take-or-pay contracts: the customer commits to buying specific volumes of memory over the term and pays for them, whether they end up wanting them or not. Most last five years -- from calendar year 2026 through late 2030, and automotive agreements generally last three. Fourteen of the first 16 add up to a combined minimum of about $100 billion in contracted revenue. That number assumes minimum volumes and prices, and management expects actual revenue to come in well above that.
Floors and ceilingsThe biggest contracts set a price ceiling for existing products around where memory was trading in the second calendar quarter of 2026, as well as a price floor that holds throughout the term. Micron says that even at the floor, these agreements would produce gross margins "well above our peak quarterly margins in any past cycle."
That claim carries weight against the sector's last downturn. In fiscal 2023, Micron's revenue fell by about half, to $15.5 billion, and the company lost $5.8 billion.
In this cycle, the gross margin hit 84.6% in the fiscal third quarter, compared with 74.4% in the prior quarter and 37.7% a year earlier, and guidance points to around 86% this quarter.
If memory prices fall, the contracted volumes are still bought -- or paid for anyway. After all, selling in a collapsing spot market is what generated that $5.8 billion annual loss, and the contracts exist to keep Micron out of that position.
But the coverage has limits. The 16 signed agreements represent about 20% of Micron's DRAM volume and around a third of its NAND volume (its two main memory chip categories) over the period. Management expects half or more of revenue to fall under these agreements once the full list is signed. Most of the business, for now, still depends on the open market.
Supply remains tight well into 2028But could a wave of new factories flood the market before the contracts prove their worth?
Not soon, according to Mehrotra, who expects 2027 to be even tighter than this year.
Micron's own construction calendar explains why. The first Boise factory isn't expected to produce wafers until mid-calendar year 2027, and the second will follow in late calendar year 2028. The New York site, where Micron broke ground in January, arrives even later. And the company expects industry DRAM and NAND supply to remain tight beyond calendar year 2027.
In short, that demand runs into significant new supply only well into the contracts' window.
Today's Change
(
-5.99
%) $
-57.87
Current Price
$
908.91
Then there's the stock's price. The growth stock, near $967 as of this writing, has more than tripled in 2026.
Even so, it trades at about 22 times earnings, and about 6 times next year's earnings. A price like that says the market expects these profits to contract.
Ultimately, these agreements help address some of the concerns about how the company can mitigate the risks of a cyclical downturn. Additionally, it stands to reason that customers with $22 billion on the table expect the shortage to last.
But a fifth of DRAM volume under contract is a start, not a transformation. Until more of the business moves to similarly contracted sales, some of the market's caution seems fair to me.
Eli Lilly ve 2. čtvrtletí zvýšila tržby o 48 % na 23 miliard USD a zvedla celoroční výhled tržeb na 85–87 miliard USD. Prodej Mounjaro vzrostl o 91 % na 9,94 miliardy USD a Zepbound o 46 % na 4,93 miliardy USD.
The obesity-drug leader is retreating despite growth that remains extraordinary by mega-cap standards. Summary
Mounjaro and Zepbound generated nearly 65% of Lilly’s quarterly revenue.
Eli Lilly LLY, the pharmaceutical heavyweight behind Mounjaro and Zepbound, slipped to $1,245.40 Monday afternoon after charging toward its 52-week high. This was profit-taking, not panic. Investors trimmed a monster winner, but the obesity-drug engine underneath the stock is still roaring.
Second-quarter revenue exploded 48% to $23 billion. Mounjaro sales nearly doubled, rocketing 91% to $9.94 billion, while Zepbound jumped 46% to $4.93 billion. Lilly then raised its full-year revenue forecast to between $85 billion and $87 billion. Few pharmaceutical giants are growing this fast at this scale.
The price tag remains brutal. Mounjaro and Zepbound already generate nearly two-thirds of companywide sales, so any manufacturing bottleneck, reimbursement squeeze or clinical stumble would hit hard. Yet the stock trades 17.97% below its GF Value estimate of roughly $1,520. That gap signals potential upside, but Lilly must keep prescriptions surging and its drug pipeline firing to earn every dollar of that premium.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
